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Executive Summary 
This summary briefly outlines the methods, findings, and recommendations of 
formative program evaluation of the Harm Reduction Initiative (HRI). Formative 
program evaluation is conducted during development and early implementation 
to ensure a program is feasible, appropriate, and acceptable.1 HRI, a program of 
KIRP, the Kentucky AIDS Drug Assistance (KADAP) Income Reinvestment 
Program, seeks to address some of the underlying causes of infectious disease 
vulnerability resulting from drug use by focusing on infectious disease testing and 
linkage to care among high risk individuals. The primary objective of the 
evaluation was to use a focused ethnographic field study approach to achieve 
the following aims: 
 
1. Characterize the need for the program 
2. Clarify the theory and logic of the program 
3. Inform implementation 
4. Improve the program where necessary 
 
METHODS 
 
Design. To conduct this formative evaluation, a focused ethnographic (FE) field 
study approach was used with the purpose of ascertaining, understanding, and 
describing the four categorical areas of formative program evaluation in the 
context of the Harm Reduction Initiative. The data collection activities included 
participant observation and semi-structured interviews. 
 
Literature Review. A literature review to understand and characterize the need 
for the program and the activities that the program should offer was completed. 
 
Setting & Participants. Primary participants included the HRI management 
team (program director, project director, medical director, strategist, program 
manager, fiscal director, DPH HRI clinical coordinator, and the director of 
evaluation and outcomes). Meeting observation and interviews took place at HRI 
offices on the University of Kentucky (UK) campus. In addition, two onsite 
meetings with local health department (LHD) personnel (public health directors, 
medical directors, nurses, and syringe service program (SSP)/Harm reduction 
workers) at the Clark County Health Department and the Lake Cumberland 
Health District office were observed.  
 
Semi-structured interviews were used for theoretical sampling when clarification 
or elaboration was needed on topics discussed during meetings. The HRI project 
director participated in these interviews which took place primarily in her office on 
the UK campus. 
 
Data Collection. Approximately 20 total hours of HRI management meeting 
observation was conducted between May and December 2019. Additionally, data 
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collection included two onsite meetings with LHD staff in the summer of 2019. 
Each of the two LHD meetings lasted approximately one and a half hours. 
Sixteen semi-structured face-to-face interviews of about 60 minutes each were 
completed with the project director. 
 
Evaluation Tool Creation. To aid the analyses and illustrate the program need, 
theory, and implementation capacity, the researcher developed problem and 
solution trees, a stakeholder analysis matrix, a logic model, and a logframe 
matrix.  These tools were produced from analysis and coding of data from 
meetings and interviews, as well as the literature review. 
 
Data Analysis. This qualitative data analysis was guided by grounded theory 
(GT) methodology, which entails starting research without a principal theory 
already established, and utilizing inductive reasoning to develop a theory after 
data collection begins. All qualitative material gathered in this study (meeting 
observation and interviews) went through a systematic, three-step, manual 
coding process starting with open coding which was refined into axial coding by 
finding relationships in the data and finally emerging into selective coding by 
identifying core categories.  
 
FINDINGS 
 
Proactive. A literature review substantiated the needs identified by stakeholders 
within the state in regards to infectious disease consequences of drug use. It 
showed that the rates of HIV, HCV, and complications secondary to drug use and 
high-risk behaviors make Kentucky’s population vulnerable to widespread and 
long-term, multi-generational consequences. Furthermore, it described the 
practices and policies that can mitigate the effects, such as harm reduction 
principles, along with infectious disease testing and linkage to care. The literature 
review laid out the landscape of causes and effects as illustrated in Problem and 
Solution Trees. This helps to better understand what the state is up against and 
how best to address the issues.  
 
Local needs were assessed through a series of meetings with health department 
personnel. Needs identified by LHD staff included more staff, funding, a user-
friendly, comprehensive data collection tool, and the capacity to access certain 
populations who cannot use syringe service programs (SSP). Some LHDs face 
opposition from law enforcement and local officials and expressed fear due to 
lack of information, training, and capacity to respond to potential outbreaks in 
their community. 
 
Clarificative. A logic model and logframe matrix, tools that illustrate the program 
logic and theory in easy-to-understand depictions were developed for the HRI. 
They lay out the inputs (resources-staff and funding), outputs (testing/linkage to 
care), outcomes (goals), assumptions, and external factors associated with the 
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program as well as the logical progression from activities through output, results, 
and purpose, to the end goal of a reduced infectious disease burden in Kentucky.  
 
Interactive. Aspects of HRI management, organization, and implementation 
strategy and practices were analyzed. A vital part of the program rollout was the 
development and improvement of the data collection tool, which is central to 
activity monitoring and goal evaluation. Additionally, managing the balance 
between state-wide standardization for quality assurance and local needs and 
nuances is critical for this innovative and much-needed program. HRI’s ability to 
review and reflect upon circumstances and adapt where necessary was 
important for effectiveness and relevancy. It became apparent that outreach work 
would be a vital component to access those in most need. Additionally, due to 
HRI’s setup and the fact that it is spread throughout the state, it will be a part of 
Kentucky’s official plan to End the HIV Epidemic. HRI solicited input from SSP 
clients in order to implement practices that are appropriate for actual needs of 
consumers and took into account perspectives of health department and SSP 
staff to address concerns.  
 
Monitoring. HRI management utilized frequent feedback from embedded staff to 
learn about and address issues. The core team has been shown to be highly 
responsive to staff needs. They have also leveraged existing strengths of 
employees while providing opportunities to support areas where improvement is 
needed. Furthermore, they continually look for ways to keep the program 
operating at the highest standard possible, including implementing a national 
Best Practices Evaluation Tool for all their sites. In addition, HRI management 
has been looking into and assessing the capacity of the state to provide data 
surveillance and outbreak response when needed. HRI is in ongoing 
conversations to support these efforts.  
 
RECOMMENDATIONS 
 
General Programmatic Issues. Findings suggest that HRI should remain in 
operation and expand to other areas of the state. Existing funds should continue 
to be used for this endeavor, as they are, to date, plentiful and versatile enough 
to allow the program to be effective. It may be beneficial to diversify funding to 
address gaps that arise due to non-allowable services (needles/syringes, HCV 
testing incentives). 
 
HRI core staff should continue their management style of seeking out further 
expertise to fill gaps in understanding and ensure staff remain as competent as 
possible. 
 
Management and embedded staff should continue to foster their consistent and 
rapid internal communication about happenings in their local areas. This 
essentially functions as a real-time alert system for important events, such as 
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potential outbreaks, mass overdose, which may indicate contaminated product in 
the area, or other sentinel events.  
 
Additionally, long term goal targets may need to be further specified.  
 
Service Expansion. Findings support continued capacity building for service 
expansion beyond SSPs to reach individuals with barriers that prevent them from 
physically coming to SSPs. County residents that cycle in and out of detention 
centers are a high-risk population and an easy point of access given they are a 
“captive audience”. Infectious disease testing, linkage to care, treatment 
initiation, medication assisted treatment (MAT), Pre-Exposure Prophylaxis 
(PreP), and vaccinations are services that could and should be offered in county 
detention centers.   
 
Local Needs Assessment. Identifying local needs was essential in determining 
what relevant services should be offered by HRI. It is important that the program 
continue to assess local needs as they change over time, particularly if 
previously identified needs are being effectively addressed. Periodic local needs 
assessments should be built into program operations. 
 
Consumer Input. Service provision should be informed by those who use the 
services. HRI should seek regular input from clients on the quality and value of 
services offered. Staff should continue to follow-up and check in with clients to 
evaluate their drug use practices to keep the offered services and activities as 
relevant as possible.  
 
Furthermore, staff should assess challenges clients face accessing SSPs, getting 
tested, and engaging in care and find ways to address them. This will require 
accumulating knowledge of available, local resources. SSP clients have indicated 
housing instability, employment, and transportation are major issues they face. 
HRI needs to be positioned to take into account these structural vulnerabilities in 
order to adequately achieve program objectives.  
 
Education/Advocacy. Findings further suggest that embedded HRI staff should 
advocate within their local communities to ensure that SSP best practices are 
implemented (i.e. needs-based syringe exchange). Furthermore, embedded HRI 
staff should continue to identify and advocate for SSPs in areas where they are 
needed but still lacking. The program should ensure adequate anti-stigma 
training including client-centered and recovery-positive language, to help reduce 
an unintentionally stigmatizing or unconsciously unwelcoming environment. HRI 
should continue to seek ways to address law enforcement interference in SSP 
operations. Progress has been made, but plans to implement an online 
educational series for law enforcement should go forward. Staff should seek 
further ways to engage local law enforcement. HRI should continue to collaborate 
with the state and other entities toward an adequate and robust data and 
surveillance system, as this is imperative to be able to identify and respond to 
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public health concerns. A last, more aspirational recommendation involves HRI 
advocating for and promoting the evidence-based harm reduction service of 
supervised injection facilities. 
 
CONCLUSIONS 
 
The purpose of this study was to conduct qualitative formative evaluation 
research on the Harm Reduction Initiative with the aim to identify the need for the 
program, clarify the program, inform implementation, and improve the program 
where necessary. The methodology and results revealed a program that was 
necessary, well thought out, carefully deployed, consistently checked for areas of 
improvement and success, and modified as necessary. This evaluation 
presented recommendations that are opportunities to further improve a well-
structured program. In order to remain effective and relevant, services must be 
restructured when necessary to address real and current issues affecting 
individuals at any given time. In this regard, the Harm Reduction Initiative is as 
prepared as can be, as it has shown itself capable of the flexibility and adaptation 
necessary to continue vital services for communities in Kentucky. 
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1. INTRODUCTION 
1.1 Background 
Infectious disease vulnerability resulting from drug use, particularly 
through injection, has had vast and devastating consequences on communities in 
Kentucky and the state as a whole.2-6 The Harm Reduction Initiative (HRI), a 
program of KIRP, the Kentucky AIDS Drug Assistance (KADAP) Income 
Reinvestment Program, seeks to address some of the underlying causes of this 
costly burden. This innovative program focuses on infectious disease testing and 
linkage to care and was in the early stages of development and implementation 
at the time of this research. This study aims to conduct a formative program 
evaluation of the HRI. Formative program evaluation is conducted during 
development and early implementation to ensure a program is feasible, 
appropriate, and acceptable.1 
 
1.1.1 Program Description  
The KIRP Harm Reduction Initiative came to be because of the 
intersection of need to reinvest program income funds and need to stem the 
infectious disease consequences of injection drug use in Kentucky. The 
conceptual impetus of KIRP is HIV prevention in high-risk populations, and the 
mission is to eliminate new HIV infections in the state by 1) providing 
comprehensive education and screening services to those at highest risk for HIV 
infection, and 2) linking identified HIV-positive persons into high-quality, state of 
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the art medical care and improving access to supportive services to ensure HIV-
positive persons enjoy health and wellbeing (See Appendix A).  
To accomplish this mission, stakeholders wanted to focus on prevention, 
education, treatment, and innovation. Therefore, four major areas of the program 
(See Figure 1.1) were set up: 
1. Harm Reduction Initiative 
2. Inter-Professional Health Education Collaborative 
3. Prevention Care and Treatment Program 
4. Innovative Pilot Programs 
 
Figure 1.1: Kentucky AIDS Drug Assistance (KADAP) Income 
Reinvestment Program (KIRP) Pillars 
 
 
Each pillar of KIRP was in various stages of development and 
implementation during the time of this study. The first area of KIRP, the Harm 
Reduction Initiative is the subject of and is discussed in detail and at length in 
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this report. The second, the Inter-Professional Health Education Collaborative will 
feature different components of education and training for providers and multi-
disciplinary care teams. The Prevention Care and Treatment Program is 
designed to invest funds into existing Ryan White programs in the state. Those 
programs will use funds to address barriers their patients experience in order to 
improve outcomes. The last area reserves funds to be used for programs 
proposed from entities within the state that are designed to improve access and 
services in innovative ways (See Figure 1.2). 
 
Figure 1.2: 
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The Harm Reduction Initiative (HRI) concept is designed to embed 
specially trained staff in local syringe service programs (SSP) in Kentucky, as 
well as infuse funds that may be used to ensure and improve testing provision 
and linkage to care. The idea is that local health departments (LHDs) where 
SSPs are located decide on what they need and want for their programs. They 
prepare and submit budget requests to HRI staff for review and approval. Thus, 
HRI exists to enhance capability of existing SSPs and focus on capacity building 
in local communities. 
HRI funding originates from Ryan White Part B funds from the Health 
Resources and Services Administration (HRSA); therefore, all expenses must 
involve the prevention of HIV for people at highest risk of infection, and linkage to 
care for people with HIV. Of note, federal funding may not be used for the 
purchase of needles or syringes. This ban dates back to 1988 legislation 
sponsored by the late Senator Jesse Helms. The law states that officials may not 
use federal dollars to provide “individuals with hypodermic needles or syringes so 
that such individuals may use illegal drugs.”7 These funds may be used in other 
allowable areas (See Appendix B), however, to offset funds that LHD allocate to 
syringes and needles.  
 
1.2 KIRP Program Origin  
In March 2019, the concept for a new program, resulting from 
collaboration between the Kentucky Department for Public Health, the University 
of Kentucky HealthCare, and local health departments in Kentucky was 
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announced via a press conference in Northern Kentucky.8-11 Northern Kentucky 
had been experiencing a cluster of HIV cases,12 and thus, stakeholders felt it to 
be a fitting location to both unveil and begin implementation of the program, 
called The Kentucky AIDS Drug Assistance Program (KADAP) Income 
Reinvestment Program, or KIRP.  
The Kentucky AIDS Drug Assistance Program or KADAP is a service 
under the Ryan White HIV/AIDS Program Part B grant.13 The Kentucky AIDS 
Drug Assistance Program Pharmacy located at the University of Kentucky 
receives 340B pricing for medications. The 340B Pricing Program is a federal 
program requiring pharmaceutical companies participating in Medicaid to provide 
certain drugs at reduced prices to healthcare providers who care for low-income 
populations.14 The ability to purchase medication for low prices combined with a 
higher post-Affordable Care Act insured patient rate, and thus more insurance 
reimbursement for medications, led to increased program income for KADAP. 
Program income must be reinvested according to allowable requirements of the 
Ryan White Program. 
In April 2017, a Ryan White Part B site visit identified that changes needed 
to be made to how the program income funds were reinvested. University of 
Kentucky Healthcare became involved, and along with Kentucky Department for 
Public Health, sought to develop a program for fund reinvestment. They enlisted 
the help of the chief of the Division of Infectious Disease at the University of 
Kentucky who oversees the Ryan White program and the Research Protocol 
Manager for the University of Kentucky Ryan White Programs due to their 
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extensive Ryan White experience. After considerable research, meetings, 
brainstorming, and consultation, these individuals submitted proposals later in 
2017. A meeting was held with the commissioner of the Kentucky Department for 
Public Health, and KIRP was eventually born. 
 
1.2.1 Structure of Public Health in Kentucky 
The structure of public health has bearing on how health policies and 
activities are handled in each state. Kentucky has a shared governance model 
between the state and local public health offices.15 Under the Cabinet for Health 
and Family Services, the Kentucky Department for Public Health’s (KDPH) 
mission is to “improve the health and safety of people in Kentucky through 
prevention, promotion and protection”.16 KDPH provides administrative guidance 
to local health departments (LHD) and relies on them to carry out lawfully 
required public health services in the state. Some LHDs are grouped into districts 
comprised of anywhere from two to ten counties. Seventy-three counties lie 
within fourteen grouped districts: Barren River, Buffalo Trace, Cumberland 
Valley, Gateway, Green River, Kentucky River, Lake Cumberland, Lincoln Trail, 
North Central, Northern Kentucky, Pennyrile, Purchase, Three Rivers, and 
WEDCO, and there are 47 standalone county health departments  (See Figure 
1.3).17 
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Figure 1.3: 
 
(Kentucky CHFS 2017) 
 
Each county has a local board of health, and districts will additionally have 
a district board of health. Boards of health assist in setting policy and priorities for 
their local area. Therefore, a district director will have to work with not only the 
district board but each individual county board as well.16 Each county has 
different political environments, rules, priorities, and perspectives. Moreover, 
each has unique requirements, challenges, and potential. This is of tremendous 
import for a statewide initiative attempting to tailor to local needs while still trying 
to keep a degree of uniformity in order to ensure a certain degree of standards 
and quality. 
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1.3 Formative Program Evaluation 
KIRP was conceived out of a need for the state to address the crises of 
drug use and infectious disease, and it is necessary to evaluate this program in 
order to ascertain whether the resources are being used appropriately and most 
effectively.  
Formative program evaluation is conducted prior to and during the 
development of a program, and it extends into the early implementation stage. 
Commonly, formative evaluation is described in four categories: proactive, 
clarificative, interactive, and monitoring.18 Other resources have described the 
four areas or stages as 1) exploration, 2) installation, 3) initial implementation, 
and 4) full implementation, but the two descriptions are essentially analogous.19 
The function of formative evaluation is to first understand and clarify the need for 
the program (proactive), to describe and clarify the project (clarificative), to 
improve the program design after initial implementation (interactive), and to 
ensure that the project is being carried out as it should be (monitoring).18 
Formative evaluation is largely conducted with the intent to improve the program, 
and this type of evaluation can also assess the readiness for summative 
evaluation.19   
Formative program evaluation can be conducted using quantitative, 
qualitative, or a mixed methodology.20 Qualitative data analysis is ideal for 
formative evaluation, as it is an exploratory process. There are activities that can 
be carried out to assess each category of evaluation (See Table 1.1). Literature 
reviews, stakeholder analyses, problem and solution tree analyses, and needs 
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assessments can be used to complete proactive evaluation. Various methods of 
laying out the program logic can clarify the program theory in the clarificative 
section. Interviews and reflection with subsequent adaptation are helpful for 
project improvement during interactive assessment, and further interviews and 
observation can be used during monitoring.18  
The purpose of this study is to conduct qualitative formative evaluation 
research on the Harm Reduction Initiative with the aim to identify the need for the 
program, clarify the program, inform implementation, and improve the program 
where necessary. The KIRP Harm Reduction Initiative seeks to mitigate the 
crises of drug use and infectious disease burden on the state. The success or 
failure of the program has serious implications for the future health and economic 
status of Kentucky. Therefore, it is necessary to ensure this project is needed, is 
organized, is effective, is adaptable, is well-managed, and targets the correct 
populations. Formative evaluation permits the discovery of any problems and 
allows them to be worked out early in development and implementation.  
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Table 1.1: Categories of Formative Evaluation 
 Proactive Clarificative  Interactive  Monitoring  
When Pre-project 
Project 
development 
Project 
implementation 
Project 
implementation 
Why 
To understand or 
clarify the need for 
the project 
To make clear the 
theory of change 
that the project is 
based on 
To improve the 
project’s design 
(continual 
improvement)  
as it is rolled out 
To ensure that the 
project activities are 
being delivered 
efficiently and 
effectively 
Examples 
Literature Review 
 
Stakeholder 
Analysis 
 
Problem / Solution 
Tree Analysis 
 
Local Needs 
Assessment 
LogFrame Matrix 
Program Logic 
 
Interviews 
Project Reflection/ 
Adaptation 
 
Observation 
Interviews 
Adapted from: Sweeney & Pritchard 2010 
 
Formative program evaluation is important because it provides a basis for 
continuation or cessation of the program or certain activities, and it may be used 
to improve project activities. Well-conducted formative program evaluation 
informs decision-making and can lend support and credibility to projects. 
Formative research should be an essential and indispensable part of all program 
development.20  
With this in mind, the KIRP Harm Reduction Initiative, as a novel project, 
is well suited to and should undergo formative program evaluation in order to 
ensure it is doing what it should be doing and addressing serious needs in the 
state.  
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2. METHODOLOGY 
2.1 Study Design 
To conduct this formative evaluation, a focused ethnographic (FE) field 
study approach was used21-24 with the purpose of ascertaining, understanding, 
and describing the four categorical areas of formative program evaluation in the 
context of the Harm Reduction Initiative. The data collection activities included 
participant observation and semi-structured interviews. 
 
2.2 Literature Review Process 
A literature review to understand and characterize the need for the 
program and the activities that the program should offer was completed. Early in 
planning the conceptual basis for the program, experts in infectious disease, 
public health, and other areas from Kentucky Department for Public Health and 
the University of Kentucky discussed the need for the program based on their 
knowledge and data at hand. This literature review serves to verify and 
corroborate what the program developers had determined to be the need for the 
program, and the appropriate services it should offer. A review of nearly 200 
articles from peer-reviewed journals, online newspaper or media, and 
governmental and non-governmental organization websites was completed to 
characterize the program need and activities.  
This literature review utilized InfoKat Discovery provided by University of 
Kentucky Libraries and the PubMed Database. Additionally, Google searches 
were performed to glean relevant information from websites of reputable 
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agencies such as the CDC, NIH, HRSA, NIDA, HHS, and SAMHSA or other 
organizations when needed. Search Terms included multiple variations of each 
topic or subject for a more thorough investigation. For example, “substance use”, 
“drug use”; “opioids”, and “addiction” were all searched. “Infectious disease” also 
included “HIV”, “hepatitis”, “endocarditis”, and others. “Harm reduction” was 
supplemented by “risk reduction”, and “syringe and needle exchange”. The terms 
“rural” and/or “Kentucky” were combined with many of the terms to provide a 
more nuanced and relevant picture of local information.  
 
2.3 Setting 
The setting for participant observation during meetings was the Harm 
Reduction Initiative Headquarters conference area on the University of Kentucky 
(UK) campus. Semi-structured interviews with the project director took place 
primarily in her office at UK’s medical center but occasionally were held in HRI 
headquarters as well.  
Additionally, two meetings occurred onsite at local departments in the 
summer of 2019. One meeting with local health department personnel took place 
at the Clark County Health Department in Winchester and the other at the Lake 
Cumberland Health District office in Somerset, Kentucky. 
 
2.4 Participants  
After being approached by the researcher with a request to complete 
formative program evaluation on the Harm Reduction Initiative, the KIRP project 
29 
director agreed to let the evaluation be done and to participate in evaluation 
activities (observation, interviews). The participants were the core HRI staff 
consisting of the program director, project director, medical director, strategist, 
program manager, fiscal director, DPH HRI clinical coordinator, and the director 
of evaluation and outcomes. Occasionally, others would attend, such a Risk 
Reduction Specialist (RRS) from a nearby county, the program manager of a 
KIRP-funded pilot program, or invited guests who had expertise to share with the 
HRI team. 
The participants of the two onsite LHD meetings included public health 
directors, medical directors, nurses, and SSP/Harm reduction workers working in 
four local departments or districts, representing a total of 13 Kentucky counties. 
In qualitative Grounded Theory (GT) methods, theoretical sampling is 
done when more information needs to be collected to clarify or refine ideas. 
Theoretical sampling deals with development of concepts and theories, and does 
not pertain to population representation or statistical generalizability.25 In this 
study, semi-structured interviews were used for theoretical sampling when 
clarification or elaboration was needed on topics discussed during meetings. 
The researcher was primarily an observer during the meetings. Clarifying 
questions served the purpose of helping participants develop the discussion at 
hand. Furthermore, while never having been employed by the KIRP program or 
HRI, the researcher was a staff member at a separate Ryan White-funded clinic 
at the time of data collection. The separate nature of funding and structure of the 
programs preempted a conflict of interest. Additionally, the Ryan White 
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experience allowed the researcher a fuller understanding of Ryan White program 
nuances. 
 
2.5 Evaluation Tool Development  
To aid the analyses and illustrate the program need, theory, and 
implementation capacity, the researcher developed several tools used in 
evaluation research, including problem and solution trees, a stakeholder analysis 
matrix, a logic model, and a logframe matrix.  These tools were produced from 
analysis and coding of data from meetings and interviews, as well as the 
literature review. 
Literature review and needs assessment discussions revealed the areas 
of focus for the problem and solution trees. To develop the HRI Stakeholder 
Analysis Matrix, basic data was filled in from information gleaned in management 
meetings but was largely completed from clarification questions asked during a 
semi-structured interview with the project director. Qualitative data coding 
revealed the resources and inputs, activities, outputs, outcomes, and other 
factors to construct the logic model as well as the activities, output, results, 
purpose, and goal details that allowed the HRI LogFrame Matrix to be created.  
 
2.6 Data Collection  
As is common in FE work, data was collected through participant 
observation.23 The observations were comprised of meetings held by the 
KIRP/HRI core team. Approximately 20 hours of near weekly HRI management 
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meeting observation was conducted between May and December 2019. 
Additionally, data collection included two onsite meetings with local health 
department (LHD) staff that the researcher attended. As stated, these meetings 
were at the Clark County Health Department in Winchester and the Lake 
Cumberland Health District office in Somerset, Kentucky. Each of the two LHD 
meetings lasted approximately one and a half hours. 
When clarification or elaboration was needed for ideas discussed in 
meetings, theoretical sampling in the form of semi-structured interviews with the 
project director occurred. Sixteen semi-structured face-to-face interviews of 
about 60 minutes each were completed. 
Audio or visual recording was not feasible for this study. A laptop was 
used to take comprehensive and thorough field notes in real-time. Details on the 
participants’ conversations as well as specifics on verbal and non-verbal 
interaction were documented. These comprehensive field notes were used for 
theoretical memoing26 and eventual coding. Soon after meetings, field notes 
were edited and revised for accuracy.  
The interview guide was simple and open-ended, which allowed new 
ideas to be brought up as a result of what the interviewee says. Not using a 
strictly structured interview set to restrict the scope of responses allowed themes 
to emerge naturally. The interview meetings with the project director began with a 
general prompt, “What’s new?” or “How’s it going?” and went from there. The 
project director openly spoke about the latest developments and any updates. 
For any clarification or elaboration needed, the questions beginning with the 
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phrases: “You mentioned…., can you tell me more about that?” or “Can you talk a 
little more about…?” were asked.  
 
2.7 Data Analysis 
The data analysis was guided by grounded theory (GT) methodology. 
Grounded theory is a method for investigating a particular topic without a 
principal theory already established, thus it utilizes inductive reasoning. This way, 
a more “contextualized theory” may emerge from data collection.27 A GT strategy 
allows for simultaneous data collection and analysis.28 The examination of the 
data starts as soon as data gathering begins and helps to focus further collection. 
Instead of preconceived notions, natural themes surface and develop from the 
data.25 GT may include qualitative or quantitative methods. In this study, a purely 
qualitative strategy was used. 
In qualitative analysis, coding is a way for the data to be managed and 
organized.28 It is how ideas and defined concepts are derived from raw data;29 
thus, it is essentially the transformation of data.28 All qualitative material gathered 
in this study (meeting observation and interviews) went through a systematic 
manual coding process. Commonly in grounded theory methodology, the 
procedure for coding is structured into three processes (See Figure 2.1). The 
initial labeling of general concepts is called open coding. Refining the open 
coding categories by finding relationships is referred to as axial coding. Finally, 
selective coding involves identifying core categories.29,30 The codebook 
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development was guided by the formative program evaluation framework, 
existing literature, and the GT three-step coding system.29,30 
Figure 2.1: 
Data Analysis Procedure Of Grounded Theory Method 
 
(Cho & Lee 2014) 
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3. RESULTS 
In this study, inductive coding was used to derive common themes. 
Thematic analysis was used to build concepts that described context, needs, 
barriers, facilitators, adaptation, and lessons learned. These processes yielded 
concepts that illustrated the categories of formative program evaluation: 
proactive, clarificative, interactive, and monitoring. Furthermore, to aid the 
analyses and illustrate the program need, theory, and implementation capacity, 
this researcher used collected data to develop several tools, including a 
stakeholder analysis matrix, problem and solution trees, logic model, and 
logframe matrix. 
 
3.1 Proactive 
The first step in formative program evaluation, proactive assessment, is 
completed in order to understand or clarify the need for the project.18 It happens 
early in program development and prior to full implementation. Literature review, 
problem/solution tree analysis, stakeholder analysis, and needs assessments 
may be conducted as part of proactive evaluation. These assessments help to 
reveal the context underlying program development.  
 
3.1.1 Understanding the Need for the Program: Literature Review   
A thorough review of current research revealed the context of the issues 
that affect the need for the program. This literature review did validate the 
circumstances that experts in infectious disease, public health, and other areas 
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from Kentucky Department for Public Health and the University of Kentucky had 
deemed necessitated the program and what the appropriate responses should 
be.  
 
3.1.1.1 The Opioid Epidemic 
For the past two decades, the United States has been experiencing a 
major public health crisis resulting from drug use.31 Opioid prescriptions 
quadrupled between 1999 and 2010.32 By the time efforts to decrease 
prescribing were put into place, many individuals had developed dependency 
and addiction, and subsequently, turned to other sources or substances when 
they could no longer obtain opioids through legal or legitimate prescriptions.32-35  
Switching from oral opioid medications to heroin or other illicit drugs led to 
an increase in injection drug use.32,33,36 Data show that between 2002 and 2011, 
four out of five heroin users stated that their opioid use started with prescription 
opioid medication for pain.32 Those using opioids non-medically have a well-
documented, increased likelihood of turning to injection as a method for 
consuming drugs and switching to heroin.36-40 
Increased use of opioids and riskier routes of consumption have created a 
crisis of non-fatal overdoses and deaths due to overdose. Those who inject drugs 
have higher rates of preventable death41 with some data showing a risk nearly 
fifteen times that of the general population.42 Studies show that injection drug use 
is more likely to result in unintentional overdose, both fatal and non-fatal.31,36,37,43 
In addition, the introduction of fentanyl to the drug supply has been especially 
36 
deadly.44 Fentanyl, 50-100 more potent than morphine, is blamed for the rapid 
nature of overdose increases in the last decade.45 
Between 1999 and 2017, overdose mortality in the U.S. tripled.31 In 2016 
alone, opioid-related deaths led to 1.7 million years of life lost.31 In 2017, this 
equated to 47,600 deaths.32 Since 1999, nearly half a million individual lives have 
been lost due to opioid overdose.32 Rates of overdose and mortality have been 
so significant, that an overall decline in life expectancy in the U.S. has been 
observed.31 
Though disturbing trends are observed across all racial and ethnic groups, 
the opioid crisis has largely affected White Americans.31 It has been particularly 
devastating to many rural areas2,32,46-48 including Appalachia.3,49 Opiate 
prescribing in Kentucky is well above the national average (79.5 prescriptions per 
100 person vs. 51.4).6 Kentucky also experiences more overdose deaths (27.9 
per 100,000 vs. 21.7 nationally in 2017),6 recently claiming the unenviable spot of 
third in the nation for overdose mortality.50 Additionally, Neonatal Abstinence 
Syndrome (NAS)/Neonatal Opioid Withdrawal Syndrome (NOWS) in Kentucky is 
more than three times the national rate: 7 cases per 1,000 hospital births 
nationally vs. 23.6 per 1,000 in Kentucky.6  
This country and Kentucky and the surrounding area in particular,2,49,51 
have experienced profound and devastating consequences from the opioid 
epidemic. Beyond overdose and mortality implications, opioid use, predominantly 
via injection, carries serious infectious disease risk. 
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3.1.1.1.1 Infectious Disease Implications 
Drug use, particularly but not exclusively, from injecting behaviors such as 
sharing needles, carries a high risk of infectious disease transmission, 
predominantly HIV and Hepatitis C transmission.36 However, other viral hepatitis 
infections, endocarditis, osteomyelitis, and various skin infections often occur.32 
Frequent or unsterile injection increases the risk of blood-borne infections.52 
Among people who inject drugs, one in three report using a syringe that had 
been used by another person.52 Furthermore, 43% of people who inject drugs 
(PWID) had given a syringe they used to someone else.52  
Research describes parallel epidemics of opioid abuse, unsterile injection 
drug use (IDU), and Hepatitis C Virus (HCV) infection.2 In the United States, 
people who inject drugs account for 70 percent of new HCV infections and nine 
percent of HIV infections.53 The opioid epidemic has caused a notable increase 
in HCV among pregnant women as well.54 The number one cause of emergency 
room visits among PWID are infections of the skin and soft tissue.55 Cellulitis and 
abscesses are common in this population and may cause more severe 
conditions such as gangrene or sepsis, which can lead to amputation or death.55 
Endocarditis, an infection within the heart chambers or valves, is highly 
associated with IDU; research has recommended hospitals and local health 
entities pay attention to rates of endocarditis in order to predict or determine IDU 
prevalence in the community.56 
Those in rural central Appalachia are experiencing disproportionate rates 
of infectious disease and its costs.49 Between 2006 and 2012, this region saw a 
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364% increase in HCV infections among younger individuals.57 Infectious 
disease consequences of the opioid epidemic have been particularly hard for 
rural areas as these areas had not previously had to deal with significant 
infectious disease events such as HIV outbreaks.32 These areas often do not 
have an adequate infrastructure in place to deal with such situations.32  
In March 2015, a public health emergency was declared as more than 200 
residents of a small rural town of 4400 were diagnosed with HIV.32 The county 
had an HIV incidence of fewer than five cases in the preceding ten years.2 This 
outbreak in the city of Austin in Scott County, Indiana was driven by the injection 
of prescription opioids.32,58 Additionally, the HCV coinfection rate during the 
outbreak was reported to be 92%.2 This outbreak led to the realization that 
nightmare scenarios such as this are very real and even likely in many places far 
from urbanized areas that are the least prepared to respond to and mitigate such 
disasters. As a result, the CDC conducted a study to identify the areas that are 
similarly vulnerable to outbreaks.32 The study identified the 220 most vulnerable 
counties in the United States.2 The majority are rural, and 54 of the 220 are in 
Kentucky (See Figure 3.1).2  
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Figure 3.1 
 
 
Kentucky has a substantial infectious disease burden. From 2008-2015, 
Kentucky led the nation in new HCV cases.59 Ninety-two percent of those cases 
were among people less than 50 years old (primarily ages 25-34), and the 
highest rates occurred in regions of Kentucky where IDU is most prevalent 
(Appalachia and Northern Kentucky).59 Rural areas with historically low rates of 
HIV are now at an increased risk due to opioid and injection drug use.60 In 
Kentucky, HIV infection among those who inject drugs is increasing in areas 
where sufficient testing was able to detect new positives.10 Northern Kentucky, 
an area comprised of Kenton, Boone, and Campbell counties just across the river 
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from Cincinnati, recently experienced an HIV cluster among the drug-using 
population12,61-63 where the HIV incidence increased by 48%.64 Clusters were 
also uncovered just across the eastern border in West Virginia,60 further 
increasing Kentucky residents’ possible exposure points. Additionally, 
endocarditis has become so prevalent among PWID in Kentucky that local 
cardiothoracic surgeons are recognizing the need to address the larger 
determinants of health and not simply the immediate infection alone.5  
Beyond the physical devastation inflicted through opioid and injection drug 
use and the resulting infectious disease morbidity and mortality, this epidemic 
has generated overwhelming economic damage as well.  
 
3.1.1.1.2 Economic Repercussions 
The opioid epidemic has caused tremendous and far-reaching economic 
distress. Low socio-economic status and unemployment are highly associated 
with substance use.59 Increasing economic development can improve 
opportunities for employment which can help decrease substance use, however 
high rates of substance use create significant hurdles for stimulating economic 
development.3 White House economic advisors estimated that the opioid 
epidemic cost the country $504 billion in 2015 alone.3  
Untreated substance abuse is associated with loss of employment,41 and 
the overall human resources impact is substantial.65 The viable US workforce has 
declined as a consequence of the opioid epidemic, which has hit adults of the 
prime working ages of 25-44 particularly hard.3 For example, the Pennsylvania 
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Chamber of commerce estimated that Pennsylvania’s epidemic was responsible 
for 20% of the workforce decline for men and 25% of the workforce decline for 
women,3 and these same statistics have been found elsewhere in the country.65 
It is estimated that opioid addiction costs employers $18 billion each year and an 
accumulated $1 trillion between 2001 and 2017.65 
Rural poverty is increasing, and a shrinking middle class is correlated with 
higher rates of drug abuse.5 Appalachia is particularly economically depressed. 
The household income in the region is only 80% of the national average.3 All this 
compounds an already risky and unstable situation. Homelessness and housing 
instability, typically seen as urban issues, have been on the rise in rural areas 
largely due to increasing addiction.66 A recent report cited that one in three rural 
Americans recognized homelessness as a problem in their community.67 
Additionally, 75% of those involved in the recent West Virginia HIV clusters 
identified as homeless or unstably housed.68  
Further economic consequences of the opioid epidemic include lost 
productivity and medical expenses36,69,70 with estimates of well over $20-$70 
billion annually.33,69 Emergency department use and inpatient admissions have 
increased due to drug use33 bringing with them astronomical financial charges. 
Hospital costs for Neonatal Abstinence Syndrome (NAS)/Neonatal Opioid 
Withdrawal Syndrome (NOWS) alone totaled over half a billion dollars in 2016.6  
Such medical costs are untenable for individuals, families, and the 
communities where they live. The severe community economic strain and 
resulting social harms further victimize these regions and individuals who are 
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already in the throes of devastating illness. This creates a cyclical mire of stigma 
from poverty, disease, and addiction. 
 
3.1.1.1.3 Stigma and the Social Construction of Populations 
Stigma involves “labeling, stereotyping, social rejection, and exclusion, as 
well as the internalization of community attitudes in the form of shame”.71 Health 
related stigma is when an individual is “devalued, rejected, or excluded based on 
having a socially discredited health condition”.72 Though detrimental for care 
delivery and treatment outcome, even healthcare workers may espouse 
stigmatizing beliefs and language towards persons with substance use issues.73 
Stigma prevents individuals from pursuing substance use treatment, adhering to 
medication regimes, being tested for infectious disease, or seeking other care 
they need.71,72,74,75 To compound the problem, individuals often experience 
intersectional stigma, or the “convergence of multiple stigmatized identities”,76 
such as being poor and rural in addition to experiencing addiction and possible 
infectious consequences.  
Stigmatized views towards groups of people lead to a social construction 
of these populations and their perceived political power (See Figure 3.2). This 
theory posits that these constructions influence agenda, tools, and rationale for 
policy. It helps explain why certain populations are seen more positively than 
others and what may facilitate policy passage or rejection. Social constructions 
become “embedded in policy” and further affect how the public regards particular 
populations.77 In this model, deviants, including ‘addicts’, belong among highly 
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undesirable populations and have little to no political power. Public perception of 
these groups is extremely low, which eases and expedites approval of punitive, 
anti-drug policies.78,79 
 
Figure 3.2: Social Constructions and Political Power: Types of Target Populations 
 
(Schneider and Ingram 1993) 
 
Justice-involved individuals when referred to as addicts, junkies, criminals, 
or deviants are cast in a negative light. These derogatory labels make it easy to 
disdain and dismiss them as deserving of punishment and undeserving of 
understanding and help. Programs such as syringe exchanges, for example, 
have always been controversial because they deal with injection drug use and 
disenfranchised populations.58 Privilege and bias have long been used to shape 
substance use policies.80  
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3.1.1.1.4 Implications of Negative Social Construction on Drug Policy 
A population having little to no political power and a negative social 
construction carries important policy implications. Stigmatizing language 
influences how politicians and voters view the population. It is much more 
palatable for constituents to vote in and approve laws and regulations that are 
extremely and entirely punitive. Such policies allowed the opioid epidemic 
situation to progress to harrowing levels without significant, effective intervention. 
The opioid problem was seen as a criminal issue rather than a public health 
emergency for a long time. The advent of the War on Drugs in the 1970s and 
further criminalization of addiction during the 1980s led to the mass incarceration 
of individuals.78,79,81 The War on Drugs is “characterized by a moralistic and 
combative approach to drug use and users”.80 During this time, funding for 
prevention was slashed, and resources for enforcement alone were ramped 
up.79,80  
When the extent of prescription opioid abuse was coming to light in the 
late 1990s and early 2000s, some lawsuits against pharmaceutical companies 
and other players were attempted early on, however, they were brought on the 
by wrong population of people: those without significant public presence or 
political sway (small town doctors, community advocates). Few substantial 
actions were taken until wealthy white people and celebrities started dying.34 
Prior to this, the only intervention was criminalization and incarceration without 
addiction support.80 Resources for prevention programs and harm reduction 
strategies have long been controversial and unpopular because of the 
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populations involved.58 Due to these circumstances, the harms of the 
prohibitionist policies have had profound legal consequences on millions of 
individuals and their communities.  
 
3.1.1.1.5 Legal and Familial Implications  
Mass incarceration of people who use drugs (PWUD) without addressing 
the underlying substance use issues has devastating effects. Untreated addiction 
damages not only individuals but also the communities where they live. 
Untreated substance abuse often leads to incarceration.41 Those convicted of 
drug crimes represent 50% of federal prison populations.79 A lack of treatment 
options has been cited for the large number of incarcerated due to substance 
use.82 Issues resulting from involvement with the justice system are extensive 
and long lasting. Disruption of stability and family dissolution are traumatic for 
adults and children alike. Growing up in a home with individuals experiencing 
substance use disorder makes children more likely to experience mental health 
issues, their own addiction, accidental poisoning, parental custody loss, and 
foster care involvement.83 Having an incarcerated parent is equally traumatic.84 
Recently, Kentucky has ranked first or second nationally for percent of 
children with incarcerated parents.82,84 The percentage (15%) is nearly twice that 
of the national average (8%).85 Subsequently, Kentucky is first in the nation for 
children who live with relatives. This is largely due to substance use and 
incarceration. Particularly concerning is the high rate of incarcerated females in 
Kentucky, many of whom are mothers.82  
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The intergenerational effects and complex nature of the opioid epidemic 
paint a grim future for the country and the state if significant and effective steps 
are not taken to combat the detrimental consequences. 
 
3.1.1.1.6 The Imperative Need to Address the Crisis 
With such profound consequences affecting nearly every facet of family 
and community life, the need to address the epidemic is vital. As it reaches 
beyond any single domain into many sectors of society, it must be tackled from 
multiple levels. Comprehensive and evidence-based approaches have 
recommended responding in six important areas: leadership, 
partnership/collaboration, epidemiology/surveillance, education/prevention, 
treatment/recovery, and harm reduction/overdose prevention.86 Coordinated 
efforts are necessary to be truly effective in mitigating harms. Even undertaking 
what may seem like only one facet of crisis, such as infectious disease 
prevention, actually requires actions in each of these areas. An HIV program 
director in West Virginia, who dealt with the HIV clusters found there, advises 
that both care and prevention continuums must be optimized in order to make a 
dent in the incidence and prevalence rates. This includes both the infected 
individuals as well as at-risk uninfected persons.68  
Infectious disease transmission resulting from the opioid epidemic is 
complex, and therefore has to be addressed in a comprehensive and practically 
effective manner. There are long-standing programs, as well as new initiatives 
that have been mobilized in an effort to prevent disease transmission.  
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3.1.1.2 Infectious Disease Prevention 
The opioid and injection drug use crises have led to higher rates of 
infectious disease transmission and severe resulting consequences. HIV and 
Hepatitis C (HCV) are the two infectious diseases most associated with injection 
drug use (IDU).2,32,57,87,88 Existing mitigation efforts have been ramped up and 
new initiatives have begun in hopes of stemming the spread of these diseases. 
 
3.1.1.2.1 Hepatitis C Virus  
By the 1980s, Hepatitis C had been detected as a separate entity from 
Hepatitis A and B. After identification, sequencing, and antibody testing 
development, prevention efforts began including blood supply screening. Rapid 
spread of HCV had happened from the 1960s through the 1980s, and million 
Americans became infected including many who still do not know it today.89 HCV 
can lead to cirrhosis and/or liver cancer; therefore, treatment is important. Early 
treatment research produced few viable options. It was not until the last five to 
ten years that safe, tolerable, and effective medications were available and 
accessible. While no vaccine exists, the infection is curable, and treatment 
options have vastly improved.89 In fact, the CDC recently added viral hepatitis to 
its “list of winnable battles”.90  
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3.1.1.2.2 HIV Initiatives 
Due to concerns of increased vulnerability to HIV outbreaks in Kentucky 
and surrounding areas, particularly where poor and rural,2 existing resources to 
prevent disease transmission are more important than ever. Additionally, new 
efforts are needed to address current gaps in care and resulting disparities in 
care and treatment. 
 
3.1.1.2.2.1 Ryan White HIV/AIDS Program 
Domestically, a key player in HIV care for the last three decades has been 
the Ryan White HIV/AIDS Program (RWHAP). Initially authorized and funded in 
1990, the U.S. Department of Health & Human Services administers the 
RWHAP, which provides medical care, support services, and medications to 
persons living with HIV. The program serves more than half of individuals in the 
United States who have been diagnosed with HIV. Patients who receive services 
from Ryan White programs show better than average outcomes including 85.9% 
viral suppression compared to the national average of 59.8%.13 
 
3.1.1.2.2.2 Ending the HIV Epidemic 
In the 2019 Presidential State of the Union Address, a new funding 
initiative to combat HIV was announced. Ending the HIV Epidemic: A Plan for 
America seeks to halt the HIV epidemic in the U.S. within ten years and will 
initially focus on areas where HIV infections are concentrated using four key 
strategies of diagnose, treat, prevent, and respond. It includes seven states, 48 
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counties, Washington D.C. and San Juan, Puerto Rico.91 Kentucky is among the 
seven targeted states and is in the midst of developing a plan for the funding and 
resources from this initiative.92  
 
3.1.1.2.3 HIV Treatment and Prevention Toolkits 
The beginnings of the HIV epidemic in the 1980s are marked with 
devastating accounts of suffering and death due to reluctance and willful refusal 
by high-level entities to address the matter, often because of political posturing 
and perceived morality concerns.93,94 Nevertheless, decades of research since 
have led to various treatment and prevention options.95 Despite the continued 
lack of a cure or vaccine, the available interventions offer effective tools with 
which to combat HIV infection (See Figure 3.3). These include medications for 
viral suppression, immune system optimization, and comorbidity management, 
as well as prevention practices such as testing and counseling, blood supply 
screening, sterile injecting equipment, pre- and post-exposure prophylaxis, 
condoms, STI treatment, mother-to-child transmission prevention, and treatment 
for drug and alcohol abuse, among others.95 These tools for treatment and 
prevention have transitioned HIV from an acute, deadly infection to a chronic, 
manageable disease, making a profound difference in the lives of those affected 
by this virus.95  
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Figure 3.3: HIV Treatment and Prevention Toolkits 
 
 
(Eisinger, Folkers & Fauci 2019) 
 
 
3.1.1.2.4 TasP: Treatment as Prevention 
Early treatment options for HIV were only marginally effective, had serious 
toxic side effects, and led to a high likelihood of developing drug resistance.96 
Highly active antiretroviral therapy (HAART), introduced in 1996 was much safer 
and more successful as an HIV treatment. HAART works toward viral 
suppression, such that transmission of HIV is nearly impossible.96 However, 
universal treatment was still not common practice until a Lancet article in 2006 
made the novel and ambitious case for treating all diagnosed individuals.97 
Montaner et al posited that, “a prevention-centered approach would argue that 
treating 100% of HIV-infected individuals at once could greatly reduce HIV 
transmission”.97 With this, the concept of “treatment as prevention” or TasP came 
to be.98 In 2016, the model of Undetectable=Untransmittable or U=U became 
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popular for prevention promotion and important for testing, linkage to care, and 
adherence to treatment. U=U encourages patients to achieve and maintain viral 
suppression so that they are unable to pass the virus on to others.99,100 More 
recently, a new angle, V=V or Viremia=Vulnerability, illustrates how “uncontrolled 
viral load (viremia) leads to vulnerabilities physically, socially and emotionally”.101 
About 40% of new HIV infections come from people who do not know they 
have HIV.102 In 2014, The Joint United Nations Programme on HIV/AIDS 
(UNAIDS) released an HIV treatment target strategy they called 90-90-90. The 
goal is for 90% of people living with HIV to know their status, 90% of those 
diagnosed to receive antiretroviral therapy, and 90% of those on ART to be virally 
suppressed.103 This target was hoped to be reached by 2020, and while not met 
in this timeframe, such goals help push for testing, treatment, and ultimately 
prevention of new cases. 
 
3.1.1.2.5 PreP: Pre-Exposure Prophylaxis 
A boon for HIV prevention came in 2012 when the FDA approved the first 
medication, Truvada, for use as a pre-exposure prophylaxis for HIV.104 
Additionally, the FDA approved a second drug, Descovy, on October 3, 2019 for 
PreP use.105 Medication taken as pre-exposure prophylaxis is highly successful 
in preventing the acquisition of HIV. Research has found either daily use or taken 
on demand to be 99% effective.95 However, uptake has been slow, with 
misinformation, misconceptions, under-informed patients and providers, lack of 
access, and financial barriers abounding.106-108 PreP deserts, or areas where 
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providers are nonexistent or difficult to reach are common in the U.S.109 PreP 
provider access issues, along with inability to pay for office visits, required 
laboratory tests, or the medication itself have been among the major 
barriers.110,111 Some public and private organizations have implemented 
programs to make PreP more accessible and affordable.91,112,113 PreP is one of 
the major strategy components of the “Prevent” arm in the Ending the HIV 
Epidemic plan.91 It has become increasingly apparent that the health benefits and 
cost effectiveness of PreP are instrumental in preventing the expensive and 
destructive transmission of this incurable infectious disease.91,95,113  
 
3.1.1.2.6 MAT: Medication-Assisted Treatment 
Another way to prevent infectious disease transmission is through 
substance use treatment. Due to the overlap in the HCV, HIV, and opioid 
epidemics, substance use treatment providers can play a unique and vital role in 
mitigating infectious disease spread as well. The principles of substance use 
treatment, “harm reduction, screening and other prevention interventions, 
treatment initiation, and linkage to ongoing medical care” are in line with those of 
HIV and viral hepatitis care.53  
When prescribed in conjunction with other therapies (behavioral 
interventions, etc.), medications used in the treatment of opioid use, such as 
naltrexone, buprenorphine, and methadone, are classified as medication-
assisted treatment or MAT.114 There are, unfortunately, addictions for which 
efficacious pharmacological treatment does not exist, such as cocaine and 
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methamphetamine.115 The National Institute on Drug Abuse (NIDA) agrees with 
the World Health Organization that long-acting medications such as 
buprenorphine and methadone are “essential medicines”.116 Treatment with 
these medications has shown to increase retention in care, decrease drug use, 
infectious disease transmission, and criminal activity, and improve social 
functioning.72,116-118 In particular, studies have shown that people with untreated 
opioid use disorder who are living with HIV and HCV are more likely to 
experience overdose and are often lost to follow up concerning their medical 
care. However, when they receive medications to treat their substance use, they 
are more engaged in their care, more adherent to HIV and HCV treatment, and 
more likely to achieve and sustain virologic suppression.119  
While use of medications to treat opioid use disorder is effective and a 
critical part of helping to curb the opioid epidemic, there are significant issues 
with access to the medications as well as a shortage of providers who will 
prescribe and monitor patients’ treatment.120,121 Only around 10-30% of patients 
with an opioid use disorder ever receive medication to treat it.118,122 Other 
challenges include cost and insurance or regulatory restrictions, along with 
medical staff disapproval of this method of treatment.118,121 Criticism that MAT 
simply substitutes one drug for another still remains among providers.123 
However, chronic management of opioid use disorder with medication reduces 
morbidity and mortality and improves social functioning by addressing such 
issues as “unemployment, disrupted family relations, and involvement with the 
criminal justice system”.124 Thus it may also be classified as part of another 
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concept that aids in the mitigation of infectious disease and substance use: harm 
reduction. 
 
3.1.1.3 Harm Reduction 
One major strategy for combatting the destruction caused by substance 
use is harm reduction. Also referred to by other names such as damage limitation 
or risk reduction, harm reduction is simply minimizing possible harms.125 The 
principles of harm reduction may be applied to a wide array of issues such as sex 
work, eating disorders, or tobacco use.126 When applied to substance use, harm 
reduction is characterized by ideas or interventions that reduce health risks when 
these risks are not able to be completely eliminated and also mitigates social and 
economic harm associated with high risk behaviors.127 It turns the focus to the 
consequences of drug use rather than the drug use itself when individuals are 
unable to stop consumption of illicit substances, and it takes into account the 
needs of these individuals.128  
Harm reduction certainly has its critics. In the same way that some 
providers object to MAT, there are those who advocate for abstinence-only 
approaches, insisting that anything less encourages drug use.126 However, one 
of the six principles of harm reduction is pragmatism, which asserts that 
substance use has been and will always be around regardless of policies or 
societal views, and therefore, everyone should operate from that mindset and 
provide services accordingly. The other principles are humanism, individualism, 
autonomy, incrementalism, and accountability without termination.126 Humanism 
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is characterized by the belief that all individuals deserve dignity and respect. 
Individualism holds that each person possesses his or her own strengths and 
needs, and there is not a ‘one size that fits all’. Furthermore, providers are there 
to educate and support, but the principle of autonomy emphasizes that the 
individual drives goal making, choices, and decisions and that both parties learn 
from each other. Incrementalism praises any positive movement however small 
and is flexible in the case of regression. The last principle of accountability 
without termination states that individuals are responsible for their choices and 
behaviors; however, they are not written off or discharged from services for 
failing to achieve goals.126 
With the advent of the AIDS epidemic, harm reduction became highly 
relevant not only for substance use but also for infectious disease 
transmission.129 Syringe exchange programs (SEPs) have been in existence 
since the 1980s in places like Amsterdam, Australia, and the United Kingdom 
when AIDS began decimating communities, and no other practices or 
interventions were successful in reducing the spread of disease.127 In the U.S., 
syringe exchange was initially informal and highly illegal. It was comprised of 
grassroots activists essentially handing out clean syringes in the street or 
distributing information about how to clean needles with bleach (including writing 
about it using “graffiti” in bathroom stalls where PWID were known to inject).130-
132  
Due to a war on drugs mentality and zero tolerance stance, harm 
reduction was not officially condoned in the United States even while AIDS 
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ravaged communities of people who used drugs.128 Politics and moral judgments 
aside, harm reduction practices including syringe service programs (SSPs) have 
been shown to be vastly effective.133 According to the CDC, barring complete 
abstinence, the safest way to inject drugs is to use sterile equipment every 
time.133 Decades of research demonstrates that SSPs are safe and not 
associated with increases in drug use or crime. In fact, SSP utilizers are more 
likely to enter treatment and stop illicit substance use. They are more likely to 
engage in primary care, which increases access to a myriad of preventative 
services, screening for serious conditions, and further opportunity for possible 
treatment including MAT. Additionally, SSPs facilitate the safe disposal of used 
injecting equipment, which reduces neighborhood litter and needlestick injuries. 
SSPs reduce overdose deaths when they provide overdose reversal drugs.133  
Comprehensive harm reduction and not simply provision of sterile 
syringes is the most effective means to prevent the spread of infectious disease. 
Comprehensive programs provide things like other injecting equipment and 
supplies (cookers, cotton, tourniquets) along with sharps containers for safe 
disposal, HIV and HCV testing, counseling, and linkage to care, access to 
overdose reversal drugs such as naloxone, referrals to substance use treatment 
and medical, mental health, and social services, education on overdose 
prevention and safer injection practices, pregnancy testing, contraception, and 
prenatal care, condoms, and vaccinations for Hepatitis A and B.68,133 Harm 
reduction is not only successful in reducing infectious disease transmission rates, 
it is cost effective. In fact, it has been described as, “cost effective in the short-
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term and cost saving in the long term” with estimates of a $100 to $1000 cost per 
HIV infection averted and $25,000-$1.8 million in cost savings per averted HIV 
infection.127  Additionally, the more comprehensive the program, the more cost-
effective and cost-saving it is.134 One study noted that a single infective 
endocarditis hospital admission ($55,700-95,700) costs more that the entire, 
initial budget of one Cincinnati syringe exchange program ($50,000).56 
Their safety and effectiveness led SSPs to be included as one of the two 
major components (along with PreP) of the “Prevent” arm of the Ending the HIV 
Epidemic ten-year plan. Kentucky is a priority jurisdiction in Phase I of the plan 
because of its infectious disease transmission vulnerability and disproportionate 
HIV incidence in rural areas.91 Comprehensive harm reduction is more important 
than ever in Kentucky. 
 
3.1.1.3.1 Harm Reduction in Kentucky 
In March 2015, the same month that an official public health emergency 
was declared in nearby Scott County, Indiana,32 legislation was passed in 
Kentucky that made SSPs legally possible.51 While syringe exchange is now 
possible, opening a program requires multiple levels of local approval. The local 
county board of health, fiscal court, and city council must all express clear 
agreement.51 Advocates in Kentucky held town hall meetings, spoke at city 
council proceedings, and launched education campaigns to dispel myths and 
provide accurate data.51 By the end of that year, there were SEPs in three 
Kentucky counties. Within two years, 31 counties had functioning syringe 
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exchange programs, another five had gained all necessary local approval, and 
ten more were in the planning stages.51 By early 2019, 50 counties were 
operating nearly 60 programs. In mid-2020, 74 syringe exchange programs can 
be found across 63 Kentucky counties (See Figure 3.4).135 The rapid and 
evidently successful nature of SSP start-ups in Kentucky belies the immense and 
challenging work that advocates went through in order to secure these victories. 
Opposition was seen from community members and elected officials alike in 
many areas.136-141 Public health campaigners, both official and grass roots, 
fought hard and continue to fight as there are still many vulnerable areas in 
Kentucky without accessible harm reduction services.  
Figure 3.4: Kentucky Syringe Services Programs 
 
(Kentucky CHFS 2020) 
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Work continues in the state to combat the opioid epidemic. Kentucky has 
a Substance Use Disorder Workgroup that advocates a three-pronged approach 
to addressing the opioid epidemic in the state. Prevention, harm reduction, and 
treatment are the focus points.142 Since much of this work had never previously 
been done, initial work by the group centered on establishing baselines and 
gathering data in order to develop future goals.142 Progress has been made in 
the state, however reports still document pushback over acceptability of harm 
reduction. Furthermore, the unavailability of sufficient data, funding, and 
resources continues to be a challenge in Kentucky.142  
 
3.1.1.3.2 Harm Reduction Programs: Access to Populations with  
     Barriers 
Harm Reduction programs have a unique opportunity to touch portions of 
a population that otherwise rarely engage with service programs and providers. 
Highly prohibitionist, punitive drug policies have driven people who use drugs 
(PWUD) ‘underground’ and ensured that they would be hesitant to access any 
type of services for fear of harassment or arrest.143 As such, this segment of the 
population is less likely to get tested for infectious disease or seek help for health 
complications. People who inject drugs (PWID) are among the least likely groups 
to get tested for HIV and are often not diagnosed until they have developed 
AIDS. This is called late diagnosis and is an indicator of much worse health 
outcomes including higher likelihood of treatment failure.144-146 Other facilities that 
60 
may have regular contact with this population, such as jails, do not typically 
provide comprehensive testing services, usually due to funding limits.143  
When deciding whether to get tested for infectious disease, PWUD face 
intersectional stigma not only from their drug use but also from potential positive 
test results. Therefore, it is a very difficult decision for these individuals to make. 
Having an environment that is open and hospitable without explicit or implicit 
disdain for their presence, allows PWUD peace of mind and safety to engage in 
screening and preventative services. Because of the nature and principles of 
harm reduction, personnel from these programs may be more likely to build 
rapport with PWUD.147 This is accomplished through nonjudgmental and 
welcoming attitudes and through the use of non-stigmatizing or “recovery positive 
language”.148,149  In order to destigmatize addiction, resources such as the 
Recovery Research Institute’s Addictionary® asserts that a unified language is 
needed and provides an online reference of terms and phrases relevant to 
substance use and recovery. Different from typical reference books, the 
Addictionary puts a “stigma alert” on entries that are deemed harmful and 
provides a peer-reviewed citation for further information.150  
Harm reduction principles align with the belief that when individuals are 
assured of the appropriate resources and support and feel they are at a place 
where they can safely and realistically seek help for their addictions, they will. 
While not a tenant of harm reduction, places that offer harm reduction services 
provide a platform and safe space for PWUD to seek out and engage in 
treatment programs.129  
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Harm reduction programs are a means to access and interact with 
populations that face significant barriers to care and services. The KIRP Harm 
Reduction Initiative (HRI) is designed to embed Harm Reduction Specialists in 
local SSPs in Kentucky. HRI, therefore, is posed to provide vital and unique 
opportunities to engage a high risk and elusive population. It should be noted that 
some advocates have recently pointed out that these populations should not be 
referred to as “hard-to-reach” since it is service providers who should be meeting 
these individuals where they are and that it is on providers to figure out better 
ways to serve these populations and not the other way around.  
 
3.1.1.3.3 Importance of Evaluative Evidence 
During creation and implementation of KIRP, multiple new SSPs were 
gaining approval and coming on board at a rather brisk rate. The last few years 
have been a time of rapid growth for SSPs in Kentucky as there has been much 
national and local attention on the injection drug epidemic and resulting issues. 
As the HRI strategist reiterated, in order to ensure sustainability, “we need to 
show that these programs are effective, and we need local proof to do that”. 
Local decision makers want to see results, and this is where robust program 
evaluation comes into play.  
The CDC notes that community acceptance has a major impact on the 
success of SSPs.133 In the midst of local support issues including law 
enforcement interference, community misperceptions, and misinformation 
campaigns, local evidence is key to sustaining high-quality, accessible services 
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for residents. As a cautionary tale, during early 2018 in West Virginia, in the 
middle of a raging opioid epidemic in highly vulnerable areas, the highest HCV 
rates in the country, and HIV cluster investigation,60 an SSP was involuntarily 
compelled by “sociopolitical forces” to choose between shutting down or having 
to implement non-evidence based, harmful practices. They shut down in order to 
avoid not only subpar but potentially detrimental service provision. Less 
availability of quality harm reduction services led to increased vulnerability in the 
local area.151 More education, research, and dissemination of accurate 
information can help rectify misunderstandings and allay concerns that lead to 
misguided actions such as incapacitating SSP operations.152   
Most existing research on SSPs and harm reduction are from urban areas. 
Only recently has research on SSPs and harm reduction in rural areas started to 
be conducted. There are still insufficient studies and data from this perspective, 
however.70,151,153,154 Dynamics are different with unique challenges encountered 
in rural spaces; therefore research is needed from these areas.   
Well-conducted research and convincing evidence can be a boon for 
policy change and pivotal for ensuring that best practices are implemented rather 
than capricious, arbitrary, and harmful policies based on whims or morality 
judgments.152 Therefore, evaluation of SSPs and other harm reduction programs 
is vital as this research assesses local needs, examines stakeholder roles, 
delves into the background and context of the problems at hand, and seeks to 
determine the most efficient and effective way to address them.    
 
63 
3.1.2 Problem/Solution Tree Analysis 
The data aggregated from the literature review corroborating the need for 
the program as identified by early program developers was used to complete a 
Problem/Solution Tree Analysis in order to identify relevant causes and effects of 
the central problem that the Harm Reduction Initiative endeavors to address. 
Conducting a Problem/Solution Tree Analysis seeks to reveal the context beyond 
the problem and further understand how to more adequately identify areas to 
tackle. This information is then laid out in a graphical depiction resembling a tree 
with branches (effects) and its roots (causes).18 
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3.1.2.1 HRI Problem Tree 
Figure 3.5: HRI Problem Tree 
 
 
The core problem identified was Kentucky’s increased burden of infectious 
disease due to injection drug use. As was discussed in planning meetings and 
similarly in the Literature Review, this burden includes HIV, Hepatitis A, B, and C, 
and injection-associated infections such as endocarditis, osteomyelitis, and skin 
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abscesses. Due to biological mechanisms and disease pathogenesis, the 
immediate effect of increased rates of infectious disease is the further, 
exponential spread of disease and the resulting complications. Increased 
incidence results in a sick population as well as higher burdens on healthcare 
facilities and providers. Healthcare providers must deal with the physical burden 
of both higher volumes of patients and an intensified severity of health 
complications for these patients. Furthermore, the fiscal impact is enormous. 
Healthcare facilities are dealing with large numbers of indigent patients with high 
acuity. Without adequate resources to fully deal with the problems at hand, much 
less the underlying cause of disease and infections, facilities are unable to 
prevent further usage of emergency departments and inpatient admissions. 
Kentucky, a state with fully expanded Medicaid and a population of 4.4 million, 
has nearly 1.4 million residents who depend on this insurance for healthcare 
coverage.155 Needless to say, the financial cost to the state government, and 
thus Kentucky taxpayers, is massive. Additionally, high numbers of deaths have 
been occurring not solely due to disease and disease complications but to 
overdose. Death, beyond the devastating emotional impact, is very costly not 
only to families but local communities where municipal resources are needed 
when morbidity and mortality occurs locally. Reduced numbers of residents and 
residents who are incapacitated because of addiction, illness, and disability 
create issues maintaining a fit and reliable workforce. Companies looking for 
areas to expand and build businesses will not locate to an area with an unstable 
or unfit workforce. Companies already located in the areas may move. Such 
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closures result in job loss and subsequent financial hardship on families and 
communities. Severe economic consequences result in areas that suffer from 
workforce problems and untenable financial burdens. These effects are seen 
graphically depicted in the top half of the Problem Tree (See Figure 3.5). 
The immediate causes of increased infectious disease burden due to 
injection drug use are the use of non-sterile equipment, undiagnosed disease, 
and untreated disease. Individuals who inject drugs sometimes share equipment 
if they are not able to obtain their own sterile injecting supplies. Reasons for not 
being able to obtain supplies for personal use include the physical absence of 
this equipment in the areas where they live because there is no accessible SSP. 
It may be cost prohibitive to purchase them from pharmacies and stores. 
Furthermore, even if there is a local SSP, law enforcement interference may 
prevent residents from getting supplies and carrying them on their person. 
Paraphernalia laws have resulted in harassment and arrest of individuals using 
SSPs. This discourages residents from returning to the SSPs. In addition, 
potentially one of the most salient reasons preventing PWID from obtaining 
sterile equipment is stigma. Fear, both perceived and realized, is a debilitating 
influence on whether PWID will go out of their way to procure sterile injecting 
equipment.  
Combined with continued high-risk behaviors, two major factors 
contributing to the spread of infectious disease are undiagnosed cases and 
known cases that remain untreated. Unknown disease in the population will 
spread uncontrolled. Pockets of disease will remain undiscovered if there are not 
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opportunities for testing available or if individuals decline testing. Undiagnosed 
individuals in the population mean that disease surveillance is inaccurate and 
unable to identify clusters and thus respond accordingly. Outbreaks will occur 
and worsen without intervention. For diagnosed individuals not engaged in care, 
significant risk for further disease transmission remains. Treatment as Prevention 
drastically reduces this risk.  Furthermore, it was noted that a major reason for 
HIV incidence is the lack of access to Pre-Exposure Prophylaxis.  
 
3.1.2.2 HRI Solution Tree 
After a thorough Problem Tree Analysis, evaluators create a Solution Tree 
(also known as an Objective Tree) by reversing the Cause-Effect areas to reveal 
the means-end relationships.18 Solution Trees highlight key points to address and 
ways to address them. 
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Figure 3.6: HRI Solution Tree 
 
 
 
Thus, in the HRI Solution Tree (See Figure 3.6), the central objective 
becomes “Lower infectious disease burden due to IVDU”.  The immediate effect 
of less infectious disease in the population is less spread of infections to others 
resulting in a healthier population. Healthier populations utilize less emergent and 
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costly healthcare, thereby saving money for individuals, families, and state 
agencies and organizations. Less disease means less death from disease and 
resulting complications. A fitter, healthier workforce provides deep economic 
benefits for communities and the state.  
In the ‘roots’ section, the causes of lower infectious disease burden are 
use of sterile injection equipment, diagnosed cases, and treated disease. Law 
enforcement support of harm reduction programs, accessible SSPs, and a 
destigmatized process all lead to sufficient, sterile equipment use for injection. 
Adequate data surveillance and ample testing opportunities ensure that pockets 
of disease are uncovered before widespread outbreaks occur. Engagement in 
care and treatment and plentiful PreP access will keep the community viral load 
levels suppressed. Harm reduction strategies keep further disease from ramping 
up and spreading.  
Problem and Solution Trees are one way to put the landscape into 
perspective and identify areas for intervention targeting. With this laid out, it is 
important to consider the entities relevant and integral to the program and their 
role in it. 
 
3.1.3 Stakeholder Analysis 
In formative evaluation, it is important to identify relevant stakeholders.18 
Often, three broad categories of stakeholders are discussed: those affected, 
those involved in operations, and those who will use the evaluation results.156 In 
this study, those affected include the clients of SSPs, the local communities, and 
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health departments. Those involved in operations are staff of local health 
departments, SSPs, and harm reduction programs, as well as the KIRP staff. The 
Kentucky Department for Public Health, KIRP, and LHD management may use 
the evaluation results.  
For a more thorough look at the stakeholders and an efficient way to 
identify and clarify the context surrounding various stakeholders, a Stakeholder 
Analysis Matrix may be completed. This document lists the stakeholder, explains 
their stake in this issue, describes how they may help the project be successful, 
and discusses level of engagement along with possible conflict among 
stakeholders.18 The HRI Stakeholder Analysis Matrix is a comprehensive listing 
of affected entities (See Table 3.1). This information was gleaned from planning 
meeting observations and reviewed and refined during project director interviews. 
Table 3.1: HRI Stakeholder Analysis Matrix  
 
ORGANIZATION NAME: KIRP Harm Reduction Initiative 
STAKEHOLDER  STAKE IN THE ISSUE  
HOW CAN THEY HELP 
THE PROJECT BE 
SUCCESSFUL 
HOW SHOULD THEY BE 
ENGAGED 
Name & brief 
description 
What is of interest to 
them, what do they 
want to see happen, 
how are they 
affected, how 
motivated are they 
etc.? 
What skills, attributes 
do they have to bring 
to the project? 
What level of 
engagement do you need 
to consider, and what 
processes of engagement 
would suit? Are there 
conflicts amongst some 
stakeholders? 
 
KIRP/HRI 
Management 
Staff (University 
of Kentucky-
based) 
 
Create, Implement, 
Monitor, Oversee 
program 
 
Very motivated to see 
program be 
successful  
Years working in 
SSP/HR 
 
Medical expertise 
 
Management 
experience 
 
Evaluation knowledge 
Highly engaged- actively 
working on development, 
implementation, 
evaluation of program  
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Embedded HRI 
Staff [RRS/ 
Associates/ etc.] 
Motivated to do their 
job well/ be 
successful  
Local geographical 
placement 
 
Likely from local 
community- inside 
knowledge/background 
Highly engaged- doing 
on-the-ground work 
directly with clients and 
working with LHD/CBO 
 
 
 
Kentucky 
Department for 
Public Health 
[Commissioner, 
staff] 
Funding oversight 
 
Motivated to see 
improvement in poor 
state statistics 
 
Also political 
motivation  
Political authority 
 
Funding authority  
Need to be engaged 
enough to be aware of 
services in order to avoid 
duplicative efforts. 
DPH HRI Administrator is 
in place for this.  
 
May be conflict between 
HRI mgmt staff and DPH 
due unforeseen or 
unavoidable delays in 
implementation. 
 
 
Local Health 
Department Staff/ 
Management  
Recipients of 
funding/staff; will 
improve their capacity 
to offer services  
 
Some staff may or 
may not be motivated 
(varying levels) 
Local knowledge 
 
Rapport with local 
community  
 
Established 
site/services 
Need to be highly 
engaged in order to work 
closely with HRI on-site 
staff daily. 
 
Potential for conflict if 
LHD wants to use 
staff/funds for duties 
outside the scope of 
agreed-upon or allowable 
services  
Staff/ 
Management of 
other Community 
Based 
Organizations 
where HRI staff 
will work 
Recipients of 
funding/staff; will 
improve their capacity 
to offer services  
 
Some staff may or 
may not be motivated 
(varying levels) 
Local knowledge 
 
Rapport with local 
community  
 
Established 
site/services 
Need to be highly 
engaged in order to work 
closely with HRI on-site 
staff daily. 
 
Potential for conflict if 
CBO wants to use 
staff/funds for duties 
outside the scope of 
agreed-upon or allowable 
services 
 
Clients of SSPs 
and CBOs where 
HRI staff will be 
 
Recipients of services 
 
Varying levels of 
motivation- may not 
be motivated at all or 
may be highly 
motivated  
Lived experience  
 
Potential to offer insight 
to improve program 
services and delivery  
Engagement/input may 
be helpful during various 
phases of implementation 
and evaluation; but not all 
May require high level of 
effort to engage due to 
barriers 
Local 
communities at-
large 
Services are being 
provided within the 
community 
Clients may be from 
local community or 
coming in from 
neighboring 
communities 
Local knowledge 
 
Relationships 
Potential for a great deal 
of conflict or for support 
 
Need to be 
engaged/educated  
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Local 
Government 
Officials/Law 
Enforcement 
Clients of HRI 
services may be seen 
as criminals/ 
undesirable/ 
undeserving to local 
officials; may be 
against SSPs 
 
Officials may be able 
to offer support for 
services, SSPs, 
treatment, etc.  
Local authority  
 
Local knowledge 
Relationships 
Potential for a great deal 
of conflict or for support  
 
Need to be 
engaged/educated 
 
It is important to have a more contextualized understanding of the entities 
involved in programming, just as it is imperative to understand and appreciate the 
complexity of the environment within which a program will be developed and 
implemented. A Local Needs Assessment is one way to more fully discern this 
environment. 
 
3.1.4 Local Needs Assessment 
For the HRI planning team, a vital component of the program is that it has 
the capacity to address local needs and take local opinions and values into 
consideration. Therefore, the program is set up in such a way that the staff hear 
firsthand and are responsive to local needs. HRI administrative staff reached out 
to local health departments and districts, both those with SSPs and without, in 
order to set up meetings to introduce the new program and offer its services. HRI 
staff traveled around the state to meet with public health personnel at or near 
their counties. Between December 5, 2018 and August 29, 2019, HRI held 
meetings at which 44 health departments and districts that cover 79 counties 
were represented. KIRP staff met with LHD representatives on-site at the local 
facilities. One, or frequently, more than one health department or district was 
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represented at each meeting. Often, neighboring departments drove in to attend 
in order to reduce the amount of travel for program staff.  
At the meetings, KIRP staff explained the reason for the program and 
what it could offer. They subsequently engaged in substantial dialog with 
attendees regarding their local needs and harm reduction and testing ideas. 
Beyond explaining KIRP and the Harm Reduction Initiative to health department 
staff, these meetings essentially functioned as focus groups that elicited an 
assessment of community needs surrounding drug use and local public health 
capacity and challenges. HD representatives were readily able to identify needs 
and possibilities for the resources that KIRP could provide. Valuable information 
and insights were gleaned as these representatives had real “boots on the 
ground” experience in their communities. These focus groups revealed that each 
area had their unique challenges, but common themes also emerged. 
 
3.1.4.1 Common Themes 
Data reduction in the form of open, axial, and selective coding was 
completed on the qualitative data gathered from meetings with LHDs. This 
allowed the information to be organized and focused into meaningful themes 
(See Table 3.2). The core categories that emerged were 1) needs or what HD 
programs are lacking in order to ensure well-run and effective harm reduction 
programs and 2) barriers that prevent adequate and effective programming.  
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Table 3.2: Local Needs Assessment Coding 
Open Coding 
(Initial concepts and categories) 
Axial  
(Refined concepts 
and categories) 
Selective 
Coding  
(Core 
Categories) 
-Not enough hours of operation due to limited 
staff 
 
-Cannot do much ID testing due to limited 
money to buy tests and supplies 
 
Underfunded/ 
Understaffed 
Needs: What is 
lacking for well-
run, effective 
program 
Some individuals will not come into SSP 
 
-May not have transportation; SSP location 
may not be accessible (at least one is right 
down the road from the police department) 
 
-There are known local “hot spots” for drug 
use 
 
Need mobile 
units/ability to help 
hard-to-reach 
populations 
-Hard to keep track of supplies, testing 
information due to non-user-friendly data 
collection system 
 
-Unable to get data from state due to 
insufficient surveillance, bureaucracy  
 
-Unable to monitor & evaluation program due 
to insufficient data 
 
Lack of Data (local 
and state) 
-So many local individuals are cycling in and 
out of county jails (due to drug use). These 
are high-risk individuals. Jails do not have 
sufficient resources or will to provide testing 
and linkage to care services 
 
-Many LHDs do not have permission or 
resources to regularly provide these services 
to incarcerated individuals 
 
-LHD staff expressed great interest in 
providing these services in jails 
 
-Incarcerated/formerly incarcerated 
individuals have expressed great interest in 
having these services available to them and 
taking part in them 
 
Lack of services for 
Incarcerated/ 
formerly 
incarcerated 
individuals creates 
a public health 
threat 
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LHD representatives spoke at length of 
extent of pushback SSPs and SSP clients get 
from law enforcement 
 
-LHD staff said police from a county where 
there is no SSP wait at the border of the 
neighboring county with an SSP on the 
days/times they know the SSP is open in 
order to stop vehicles coming from the SSP  
 
-Staff at one county SSP state they advise 
their clients to hide the supplies received 
from SSP because staff know that local law 
enforcement are aggressively opposed to 
SSP 
 
-SSP staff have advised clients to use 
children’s metal lunchboxes or similar item as 
a sharps container so cops are less 
suspecting 
 
Law Enforcement 
Interference 
Barriers to 
effective program 
LHD staff stated some of their local officials 
deny there is a drug problem in their county, 
therefore oppose SSPs 
 
-LHD staff member spoke of introducing 
overdose maps to visually show one 
dimension of the local drug problem 
 
-One county has harm reduction program 
without needle exchange and keep inviting 
local officials and law enforcement to 
community forums, but they do not attend 
and will not engage in dialog with harm 
reduction advocates 
 
Local Official 
Opposition 
LHD staff expressed a fear of “HIV” coming to 
their community. One nurse stated she would 
not know what to do for the patient. She had 
no idea where to refer the patient for care. 
  
-Another stated that her colleague had tested 
a patient and the result was positive. The 
staff member was so distraught that she 
could not even speak to the patient.  
 
-Staff expressed fear of outbreak (such as 
Scott Co Indiana). Stated they know that 
locally they do not have the capacity to 
respond and do not believe the state does 
either.  
Fear/lack of 
information: 
outbreak without 
capacity to respond 
on local or state 
level 
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Within the “needs” category, insufficient funding, staff, and resources were 
pervasive, recurring themes. These shortages prevented SSPs from offering 
ample or convenient operational hours and left very little, if any, capacity for 
infectious disease testing onsite. LHDs also stated that they know there are 
portions of high-risk populations who will not come to SSP for various reasons. 
LHDs conveyed interest in mobile units and resources for outreach to service 
local ‘hot spots’ for drug use.  
Also in the “needs” category, the lack of data was discussed. A need 
expressed by LHDs/SSPs was a user-friendly data collection tool that could also 
function as a way to pull data for their own evaluative purposes. They must report 
certain information to the state, but have significant issues getting data back from 
the state. This was one of the most voiced and prevalent issues mentioned by 
LHD representatives.  
Additionally, LHDs articulated an imperative need for services for 
incarcerated and formerly incarcerated residents in their local communities. 
There is a large number of individuals cycling in and out of detention centers due 
to drug use. These individuals are at a high risk for infectious disease acquisition 
and transmission. LHDs state that local jails need testing and linkage to care 
services. LHD representatives indicated that they would be happy to provide 
these services onsite in the jails if they had the resources and permission. The 
representatives stated that jails are a good place to target testing and vaccination 
provision since, as one SSP representative said, this is “literally a captive 
audience”. Furthermore, they stated that inmates really wanted and appreciated 
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the services offered onsite by LHDs. Several sites mentioned that they have 
used small grants or other limited funding they have scraped together to provide 
some services at their local jails with great success. 
The second major category to emerge was that of barriers encountered by 
LHDs and their SSPs. The most voiced concern in this area was interference 
from law enforcement. Representatives spoke about law enforcement waiting at 
the county line or down the road from the SSPs in order to stop clients traveling 
from SSP sites. One county said they explicitly told their clients to hide the 
supplies they get from the SSP because they know the local police are 
aggressively opposed to syringe exchange. Others advise clients to use 
children’s metal lunchboxes or other nondescript items as sharps containers so 
that law enforcement will be less suspicious. 
An additional impediment is opposition from local government officials. 
LHDs said that they have heard their local officials deny that there is a drug 
problem in their area. One HD representative spoke about introducing overdose 
maps to visually show that there is in fact a problem. One representative from a 
county that did not have an operating SSP stated that they (the local Harm 
Reduction advocates) keep inviting local officials and law enforcement to 
community education forums, but the officials do not attend and will not engage 
with them.  
A third barrier was that of fear resulting from a lack of information and 
education. LHD staff voiced fear of an HIV outbreak knowing they have very 
limited capacity to respond. One HD nurse who works in an SSP stated they are 
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very worried about “HIV coming to their community”. She said they need a 
framework or work plan in place for when “HIV hits”. She stated they do not 
currently have a strategy. Additionally, the state does not have the capacity to 
handle an increase in diagnoses.  
Having solicited needs, concerns, challenges, ideas, and plans from local 
public health staff, HRI set out to further design and implement a program that is 
responsive to local needs.    
 
3.2 Clarificative 
In this study, data was gathered and analyzed to form a contextualized 
landscape of program need, development and implementation. Grounded Theory 
guided qualitative coding of the results of the next three categories of formative 
program evaluation, clarificative, interactive, and monitoring, can be seen in 
Table 3.4.  
The second category in formative evaluation is the clarificative category. 
The goal of this category is to describe the program and the theory behind it. 
Tools commonly used in planning, development, and evaluation may be used. A 
Logic Model and Logical Framework Approach Matrix were constructed from the 
relevant data collected for this step of the evaluation. 
 
3.2.1 Developing Goals 
In the evolution of program development, once the program and project 
directors, medical director, and HRI strategist were on board, regular meetings 
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continued to further develop and implement the components of the Harm 
Reductive Initiative. The core team grew as new staff were hired: a program 
manager, a fiscal director, a DPH HRI clinical coordinator (also called HRI DPH 
administrator), and a director of evaluation and outcomes. The next important 
step was to establish objectives and goals to guide program activities toward 
targets. Objective and goal development are key steps to position a program for 
success and effective evaluation. The first iterations of goal brainstorming by HRI 
staff were referred to as “moonshots” as they were ambitious targets. Preliminary 
discussion of potential objectives for the Harm Reduction Initiative produced 
ideas that the staff would further examine: 
 HIV status awareness for PWID increases 
 Linkages to HIV/HCV treatment 
 Kentucky’s HCV state ranking drops from X to Y 
 Overdose rates drop  
 Reduction in syringe litter  
 Increase MAT and substance use treatment 
 
HRI staff held a meeting in August 2019 dedicated to discussing program 
goals, how to quantify them, and how to measure the success of program 
activities. HRI administrative staff decided against setting test quotas for the first 
year. The first year objectives would concentrate on setting up staff and 
beginning to offer services. Furthermore, the goals set during this time would 
apply to clients encountered within SSPs only and not outreach activities since it 
was not yet clear which counties would have the capacity to perform outreach. 
This is all dependent on a particular site’s hours of operation and how busy they 
are during operation. It may not be possible for a Risk Reduction Specialist 
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(RRS) in a particular county to be away from the SSP for long. It was decided 
that at the end of the current fiscal year, HRI core staff would assess each county 
and available local HRI staff to determine who will be able to perform outreach 
activities. This will also be dependent on available opportunities within the 
community. For example, counties with college campuses or numerous faith-
based organizations may have ample places in which to carry out outreach 
activities. It is expected that upon starting employment, RRSs will explore the 
possibilities for outreach in their areas, but there is no expectation that activities 
will be undertaken at that time.  
Measurable goals that were discussed and established were organized into 
three categories. Short, intermediate, and long-term targets were laid out along 
with the time frame for completion and assessment.  
 
3.2.1.1 Short Term 
 Recognizing high risk/vulnerable populations  
 Timeframe: (Fiscal year) July 1, 2019-June 30, 2020 
 
Goal discussions first included how the program would recognize vulnerable 
populations and who to define as high-risk. It was noted that the vulnerable 
expose others who are not classified as high risk, thus the infectious disease 
implications are far-reaching. The KIRP program director mentioned the story of 
a woman in an Eastern Kentucky county who was recently diagnosed with HIV 
after her newborn baby became very ill and tested positive. The women had 
been in a monogamous relationship. Her partner, unbeknownst to her, was high-
risk and HIV-positive. The HRI medical director noted, “This is not the Kentucky 
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of 20 years ago”. Many programs are using CDC vulnerable county data2 (Refer 
to Figure 3.1) to set standards for high-risk areas, however HRI staff pointed out 
that the data is now old, and furthermore, by using more local data, they could 
define a more expanded base. The HRI medical director believed the Hepatitis C 
rate to be an adequate marker of HIV risk due to similarities in risk factors and 
modes of transmission. HRI decided to deem each county Tier 1, 2, 3, or 4 based 
on HCV rate information from the Kentucky Department for Public Health (See 
Figure 3.7). The objective established was to embed RRSs in 100% of Tier 1 and 
2 counties, which have the highest HCV rates. Tier 3 counties would be targeted 
for an at least 75% HRI presence and 50% in Tier 4 counties.  
Figure 3.7:  
 
  From: KDPH 
 
Shortly after this goal discussion, HRI staff learned that results from a new 
vulnerability study conducted by the state of Kentucky would soon be released by 
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DPH. Staff decided that this local and more recent data would be used to assign 
tiers to counties. They stated that they anticipated these results would add some 
counties to the HRI list that were not there before. Consequently, this goal will be 
more fully assessed after the release of the report.  
 
3.2.1.2 Intermediate Term 
 Focus on Testing  
 Timeframe: 12 months after local HRI staff begin employment 
 
Intermediate goals center on testing and linkage to care. HRI would like 25% 
of all clients encountered in SSPs to be tested for HIV regardless of if or how 
they use drugs. Additionally, in order to target higher risk and more vulnerable 
individuals, they want 50% of PWID tested. HRI would like a minimum of 25% of 
clients to get tested at least twice a year. Staff noted that local RRSs must build 
trust and rapport to convince these individuals to be tested. The timeline for 
intermediate goals will vary by site. Dates depend on when local HRI staff began 
employment.  
The REDcap data collection tool can keep track of the number of tests 
performed. Additionally, local staff will have this information completed on 
quarterly report forms (Refer to Appendix F). The availability and reliability of 
baseline data, however, is questionable. HRI staff will only have access to tests 
done at LHDs and not elsewhere in the community. The director of evaluation 
and outcomes will look into getting access to state data, though this is typically a 
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cumbersome process. The difficulty in retrieving data from the state was a 
complaint frequently voiced by LHDs.  
In order to assess whether the appropriate participants are being targeted, 
HRI will look at the positivity rate of testing. The positivity rate is the proportion of 
tested individuals with positive results. A low positivity rate means that the wrong 
people (i.e. low risk) are being tested. Thus, resources are not being targeted 
appropriately. The HRI project director believes the CDC overall HIV positivity 
rate goal is 1%. Therefore, HRI set their goal higher since they are targeting 
high-risk individuals. They will start with a 2% goal and review to potentially 
reassess after some time. The goal for the HCV positivity rate for the first year is 
10%. HCV has a much higher prevalence than HIV. HRI staff report that the 
University of Kentucky emergency department universal testing rate is 11%, 
therefore, they feel that a 10% rate is realistic. 
Linkage to care for individuals testing positive is the next priority. To align with 
90/90/90 treatment targets,103 the HRI goal is to connect 90% of those testing 
positive for HIV to care. For those testing positive for HCV, the goal is to link 50% 
to care. For the Madison County syphilis testing pilot project, 100% of positives 
will be linked to care.  RRSs will refer patients to care for any positive tests. This 
means that RRSs will need to be familiar with local resources in order to know 
where and how to refer.  
HRI chose to define linkage to care or a completed referral as the patient 
keeping the first referral appointment. At that point, HRI will drop out and cease 
tracking the patient. There are issues regarding how to keep track of referrals 
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and appointments. As of the end of 2019, this situation was still fluid, but 
brainstormed solutions included assigning team leads to make follow-up calls, 
utilizing an anticipated hepatitis grant which would hire navigators, and/or utilizing 
linkage navigators for HIV that would be funded through Part B rebate dollars. 
Patients would also need to sign Release of Information forms to give HRI staff 
permission to follow up on appointments.  
 
3.2.1.3 Long term 
 Universal Testing, PreP Access 
 Time Frame: Varies 
 
HRI laid out several longer-term initiatives they felt were important to address. 
The timeframe for most of these goals is 12-24 months after local HRI staff begin 
employment. Again, dates and timelines will vary by site as staff were hired at 
different times.  
It has been the HRI medical director’s firm and passionate belief that HIV care 
should to be integrated into general medicine. She asserts that healthcare 
practice should mainstream concepts around HIV testing and care. To this end, 
the HRI would like to pursue several initiatives to improve this area.  
 
3.2.1.3.1 Emergency Department HIV Testing 
HRI core staff envision that KIRP could be an instigator of pushing 
universal HIV testing in emergency departments. Additionally, the program could 
work to stimulate the infrastructure for testing in urgent treatment and walk-in 
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clinics.  The staff noted that PWID are often high-utilizers of emergency and 
urgent services, thus these facilities are good opportunities to reach these 
populations. Currently, whether a particular hospital or clinic performs universal 
HIV testing depends on individual institutional regulations. 
HRI management decided that embedded HRI staff will make in-person 
educational contact with at least three unique facilities in their county or area. 
They will target ER managers or nurse managers. RRSs will also explain that 
they are available to ERs to test or deliver results and link to care.  
 
3.2.1.2.2 Testing in MAT Programs 
Additionally, universal HIV testing should be occurring in Medication-
Assisted Treatment (MAT) programs. The HRI medical director asserted that 
these facilities are not testing enough even though they have been advised to. It 
is uncertain how consistent they are. She noted that it often depends on 
economics. HRI core staff emphasized that RRSs could test at MAT programs, 
however, they were unsure as to the best way to connect with these programs. 
The good ones are likely testing already, but HRI staff noted that some MAT 
programs are erratic, “fly-by-night” types of facilities. It was decided that the HRI 
DPH clinical coordinator would speak to KORE (Kentucky Opioid Response 
Effort) representatives to see the best way to go about this. HRI management 
staff decided that MAT programs can be included in the three unique facility 
contact goal.  
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3.2.1.3.3 PreP Access 
The “dream” of the HRI core staff is to get LHDs to become PreP 
providers since there are currently very few. This vision is a much longer 5-10 
year goal and involves considerable educational components. This would include 
reviewing core services guides for LHDs, highlighting the fact that APRNs can 
prescribe under their own licenses, and hosting educational opportunities such 
as webinars and/or in-person trainings. Currently, Christian County is piloting a 
PreP-prescribing program. The more immediate goal for embedded HRI staff is 
to identify at least three unique prescribers in their area who are interested in 
prescribing PreP and begin education with them. The end goal is to have at least 
one provider who prescribes PreP in each area in the state.  
 
3.2.2 Logic Model  
Each of these established goals can be seen in the HRI Logic Model (See 
Figure 3.8). A logic model lays out the underlying theory of the program. It links 
outcomes with activities and processes.157 It is a clear, visual way to depict 
program features. The logic model for the Harm Reduction Initiative was 
developed with information from HRI meetings and interviews.  
First, inputs are listed. For HRI, these include funding for staff, training, 
travel, technology, supplies and test kits, educational materials and literature, 
office supplies and equipment, office improvements, office space rental, data 
collection program, and incentives.  
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Next, outputs including activities and the recipients of the services are 
recorded. All testing, education, supplies, and linkage to care activities are for 
SSP clients. HRI staff and stakeholders will utilize needs assessment and 
evaluation results. The collaboration with HRI is advantageous for LHDs and the 
local community. Everyone involved benefits from an informed, non-judgmental 
environment that does not foment stigma. On the far right of the logic model, 
outcome performance measures are indicated. The short, intermediate, and long-
term goals can be seen.  
Lying outside the inputs, outputs, and impact assessment are critical 
assumptions and external factors. Program evaluation measures can be put into 
place to gauge the extent to which assumptions and external factors impact the 
program. Assumptions in this Logic Model include: 1) local health department 
and districts will be open to participation, 2) funding will be adequate and used 
appropriately, 3) clients will want to use SSP services and know their disease 
status, 4) program will target the correct populations, and 5) staff biases will not 
affect service provision. External factors include either support or interference 
from the community and law enforcement, existing policies, and the geographical 
and socio-economic status of the area.  
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Figure 3.8 Harm Reduction Initiative Logic Model 
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3.2.3 Logical Framework Approach Matrix  
A Logical Framework Approach Matrix, or Logframe Matrix, is another way 
to conceptualize aspects of a program, similar to a logic model but with a 
different approach and layout. A LogFrame Matrix outlines features that lead to 
the achievement of program goals (See Figure 3.9).18  
 
Figure 3.9: LogFrame Matrix 
 
The LogFrame Matrix stems from a Logical Framework or LogFrame 
Approach used in project planning. A LogFrame Approach starts with a 
stakeholder analysis and a problem/solution tree analysis. The matrix is read 
from the bottom up. The first column characterizes the logical progression from 
activities to outcomes that should occur. The second and third columns indicate a 
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measure of whether the first column was achieved and how you know. The 
assumptions represent potential risk that should be carefully considered. If all 
goes well on the first row, then you successfully progress to the next step 
above.18 The LogFrame Matrix for the Harm Reduction Initiative can be seen in 
Table 3.3.   
 
Table 3.3: Harm Reduction Initiative LogFrame Matrix 
Objectives Indicator Data Source Assumption/Risk 
Goal Reduction in 
Kentucky’s 
infectious disease 
burden 
REDCap, State data  
Purpose Increase in linkage 
to care 
Partners (DIS, HCV 
navigators); follow 
up w/RW programs, 
LHDs, other ID 
providers 
Referrals are 
completed and 
clients engage in 
treatment 
Results Increase in high-
risk positives 
identified 
Quarterly Reports; 
REDCap data 
Those identified will 
successfully be 
referred to care 
Output Tests performed  Quarterly Reports; 
REDCap data 
Target population is 
being reached 
Activities Personnel, training, 
equipment, supplies 
HRI core staff 
records 
Sites will be fully 
staffed, trained, and 
resourced in order to 
carry out duties 
 
3.2.4 Diffusion of Program Awareness  
Advertising the program adequately was an important step to ensure the 
greatest reach, utilization, and effectiveness. HRI core staff has engaged in 
various methods to disseminate program information. They completed numerous 
direct contacts in the form of phone calls, emails, and face-to-face encounters 
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with health department directors, community organizations, and other relevant 
stakeholders throughout the state. The press conference in Northern Kentucky in 
March 2019 resulted in online and print news articles and social media 
attention.8-11 Beyond individual meetings with LHDs and the initial press 
conference, HRI co-hosted and presented at the Kentucky Harm Reduction 
Summit in April 2019. It also leads both in-person and webinar-based AIDS 
Education Training Center (AETC) conferences. HRI core staff have attended 
and continue to attend various other conferences and events throughout the 
state to increase diffusion of HRI program awareness and encourage uptake and 
engagement in the program.  
 
3.3 Interactive 
Interactive evaluation is carried out during early implementation and is 
used to improve the design of a program.18 Evaluation during implementation 
seeks to reveal the lessons that emerge at this time and can be used to modify 
processes early on. In this study, meetings with staff and open-ended interviews 
when needed allowed relevant information and issues to surface naturally. 
 
3.3.1 Organization, Development & Implementation Strategy 
Throughout meeting observation and interviews, themes emerged that 
illustrated program strategy with respect to its organization, development, and 
implementation.  
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The staff consistently sought out advice, guidance, and expertise on topics 
so that they would be optimally informed for decision-making. Though there were 
decades of infectious disease, harm reduction, and grant management 
experience represented on the team, they did not presume to know exactly what 
to do all time. When new topics or issues arose, they pursued information, paid 
attention, sought to understand, and took more informed action. This was 
observed when the core team invited a professor to share her recent research 
studying local SSPs and when they had a software developer in to explain the 
options available for data collection tools.  
For the program to work well, the staff must be highly organized. Special 
meetings were dedicated to deciding how program processes and 
implementation would be tracked. For logistical support of a large and complex 
program, a Kanban system was employed. Kanban is a system originally used in 
manufacturing and designed for workflow management. It has been developed 
into software that keeps track of and visually follows the progress of program 
development and implementation (See Figure 3.10).158 The online Kanban 
system keeps track of each LHD contact and meeting, budget requests received 
and approved, position postings, hiring, and more.  
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Figure 3.10: Example of Kanban Board 
 
 
Prior to HRI, the capacity of organizations (SSPs and others) to provide 
testing and linkage to care was extremely limited. As illustrated on the 
Problem/Solution Tree Analysis, HRI focuses on the right side causes (testing 
opportunities, data collection, linkage to and engagement in care), but builds 
capacity for left side causes (sterile injection equipment provision, reduction in 
fear, stigma, and interference). For embedded staff in counties with no SSPs, 
one of their job duties will include advocacy for setting up syringe exchange 
programs as well as outreach. The Harm Reduction Initiative is limited from a 
funding perspective in that it must operate within federal Ryan White program 
guidelines (See Appendix B).13 HRI is not able to purchase syringes, cookers, or 
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other equipment legally deemed to be ‘paraphernalia’. Program activities and 
supplies are also subject to local laws and regulations.  
One of the main objectives of the Harm Reduction Initiative is to hire local 
Risk Reduction Specialists to be embedded into local syringe exchange 
programs, harm reduction programs without syringe exchanges, and other 
community based organizations.  Under the original conception, LHDs would 
essentially write their own job descriptions for the positions they desire at their 
facility. Although these positions would be paid through the University of 
Kentucky and receive UK benefits, they will be locally selected and stationed. 
Furthermore, there will be local oversight. Positions are posted via the University 
of Kentucky Human Resources website (See Appendix D). The project director 
shares the link with the respective health department director who then 
advertises via their email lists, social media pages, websites, and any other 
venues they deem appropriate.  
Besides staff, allowable costs include supplies (other than injecting 
equipment), travel, training, HIV and HCV tests, outreach and education 
materials, client incentives, and office space rent. Each Risk Reduction Specialist 
position includes an annual budget of up to $242,402 (See Appendix E). Each 
staff member hired will undergo several trainings including UK New Staff 
Orientations; Harm Reduction Navigator training, and training on HIV, HCV, and 
syphilis testing.  
HRI’s focus is on infectious disease testing. Due to the nature of its 
funding, HIV is the main emphasis. However, HCV, being so highly co-
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diagnosed, is an important indicator in HIV risk. Furthermore, it was decided that 
HRI would conduct syphilis testing in addition to HIV and HCV because there 
was a new, rapid syphilis test available, and rates of syphilis in Kentucky were 
rising. This is concerning for HIV prevention because syphilis is associated with 
increased risk for contracting HIV, according to DPH and HRI medical staff. The 
new syphilis test will be piloted in Madison County, the first HRI county to fully 
come on board. Once the Department for Public Health determines how positive 
syphilis referrals will affect their workflow and if they have the capacity to handle 
all the positives, it will be decided whether to roll out rapid syphilis testing in other 
counties.  
The management team decided that for ongoing evaluative measures, 
quarterly reports will be completed from each site. These reports would include 
summaries of relevant areas such as successes, barriers, and a data table with 
the number of tests, distribution of supplies, referrals to care, and a brief 
narrative of activities (See Appendix F). HRI administrative staff will review data 
on a regular basis to assess effectiveness.  
Beyond the periodic information on program activities, considering the 
major focus of the initiative is infectious disease screening and linkage to care, 
real-time tracking for testing is essential. In order to have meaningful data, 
designing an adequate, useful, and user-friendly collection tool was critical. Being 
able to document program activities and progress toward target goals is among 
the most fundamental requirements for assessing program success.  
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3.3.2 Data Collection Tool 
One of the early priorities was devising a way to capture and measure 
services and outcomes in order to keep operations on track and evaluate 
success. HRI staff and relevant stakeholders spent significant time discussing 
data and data collection. In order to set and measure goals and objectives, 
relevant and appropriate data must be collected in a way that allows for 
meaningful analysis and demonstrates targeted outcomes.  
The team discussed that current state-level data on the true incidence and 
positivity rates for HIV and HCV are not accurate, if they exist at all. Thus, if data 
collection is done right, HRI could potentially become a starting place for this kind 
of data in the state. It was noted that with more than fifty possible sites and more 
individual staff members collecting data, uniformity is vital in order to allow 
statistical analysis.  
HRI staff strove to put emphasis on local input and feedback in all areas. 
In developing a new data collection system, it was suggested that a survey be 
sent out to all the health departments and SSPs in the state with the new 
proposed client questions to elicit thoughts and any additional information that 
may be helpful. Mention was made that if possible, client feedback would be 
useful. It is unknown if actual clients have ever been consulted in the formation of 
Kentucky SSP data questions and procedures. 
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3.3.2.1 REDCap 
An existing data collection system created and advocated for by the DPH 
(REDCap) was largely found by SSP staff to be non-user-friendly, and therefore, 
not generally used appropriately, if at all, in individual SSPs. One LHD 
representative described REDCap: “It’s difficult, and it’s difficult”. Another SSP 
representative said that it is “important to be able to pull data in minutes, not 
days” to show stakeholders. As it was, the intake and testing questions in 
REDCap were cumbersome, out of order, difficult to maneuver through, and hard 
to complete in their entirety, thus they rarely ever were. The data pulled from the 
platform was abysmal when HRI began to look into it.  
A consultation was held with a software developer to discuss the 
possibility of creating a program from scratch that meets the exact specifications 
of the HRI and SSP staff in a user and client-friendly way. Meanwhile, the HRI 
strategist and the director of evaluation and outcomes held a meeting with state 
employees to discuss the limitations of REDCap. It was agreed that REDCap 
would be modified. 
In the improved version, there were collapsible sections that were grouped 
in an order that made sense. It was user-friendly and not time consuming as it 
was appropriately shortened without sacrificing necessary data. It was also 
decided that pop-up alerts were needed to inform staff when a client was due for 
testing. A webinar for a small test group of users to pilot the new version was 
held on July 22, 2019. However, several glitches and errors were encountered, 
and the webinar was set to be rescheduled and attempted again at a later date 
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after some modifications could be made. After several iterations of the system, 
the current version went live on September 2, 2019. The first round of data was 
reviewed the first week of October 2019.  
 
3.3.3 State-Wide Standardization and Local Decision-Making 
Due to the structure of Public Health in Kentucky and state regulations, 
each site within each health department or district is different and has its own 
needs and distinctions. Allowing for local decision-making presents both 
advantages and challenges. Ensuring standardization while still addressing 
individual site nuances requires a delicate balance. This makes implementation 
difficult, as each process will look a little different. The mantra, heard many times 
over during meetings is, “If you’ve seen one health department, you’ve seen 
one.” Often, the single commonality will be these HRI positions, which afford an 
opportunity for some standardization in order to implement best practices while 
still keeping local needs in the forefront.  
 
3.3.4 Challenge of Innovative Programming 
Being a completely innovative program, there were no existing plans, 
policies, or procedures in place when stakeholders set out to develop KIRP. 
Everything had to be built from the ground up. In doing so, they kept in mind the 
tenuousness of the situation. HRI staff knew that once the initial RRSs started in 
the field, there would be unforeseen issues that arise and many challenges. The 
management staff was prepared for this. Therefore, when an issue has surfaced, 
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the team has not yielded to chaos or panic resulting in hasty decisions. The staff 
discusses the issue to decide upon a plan of action. Then the project director 
writes up a preliminary draft of a policy, which she sends out to RRSs in the field 
to review. Feedback from the field staff is incorporated when applicable and 
appropriate. 
Administrative staff members are also open to realizing and utilizing 
strengths of staff and the existing syringe service or harm reduction programs. 
For example, HRI identified that Madison County was strong in the area of policy 
and procedure development and had a robust set of policies and procedures for 
their programming. Therefore, HRI has solicited and utilized their assistance in 
building HRI policies. Additionally, at the time, both Christian and Bell Counties 
lacked syringe exchange programs, and local HRI staff were working to get 
approval for one. The staff members from each county began communicating 
with each other to share advice and help each other with lessons learned. 
With new staff and an infusion of funding, SSPs and harm reduction 
programs have the freedom to innovate and explore options that were previously 
unavailable due to restrictions of personnel and money. This ability is novel. The 
project director stated that “go-getters” are needed in each county to fully utilize 
and realize the potential that each program has. She states that the innovation 
that local HRI staff bring to each SSP or harm reduction program will ultimately 
dictate what happens and how successful the program is.  
HRI management staff wants to use what is essentially peer-pressure to 
push RRSs to be innovative and achieve. Embedded staff communicate with 
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each other extensively through email lists, meetings, and other venues. They 
share challenges, ideas, and new things they are doing. Management hopes that 
this constant encouragement and reminder of what is possible will prevent 
underperformance or complacency in embedded staff.  
 
3.3.5 Review, Reflection, and Adaptation 
For any program, particularly new ones, challenges to implementation and 
sustainability require adaptation. During the interactive stage of evaluation, early 
implementers are studied to assess what the barriers and facilitators are; what 
conditions make it harder or easier to carry out activities.159 These discussions 
occurred during HRI meetings and interviews. 
  In the course of creating and implementing local-need-specific 
programming state-wide, all within federal guidelines, the team unsurprisingly 
encountered numerous challenges. The complexity of working with several 
distinct entities creates multiple layers of bureaucracy and so-called ‘red tape’. 
Each step of the way takes time, and a hold-up in one area will affect each 
successive step. These delays created frustration for some partners ‘higher up’ 
the chain. While there were no official timelines set ahead of time, some entities, 
particularly those who may have political constituencies, had expectations for 
more prompt results. One area of delay stemmed from the legal and contracting 
nuances required for approval and implementation. The main point of contact for 
contracting was out on leave before new contract management positions were 
filled, and this slowed things down significantly.  
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Additionally, a changeover of public health commissioner in the midst of 
development planning created some interruption. This required that new 
relationships, understandings, and expectations be established mid-way through. 
While not a major impediment, it did generate more work for HRI staff, which 
shifted their focus from other tasks that could be done. 
From the time budget requests from LHDs started rolling in, the HRI 
organizational chart was in a constant state of flux. It was changed to adapt to 
the actual, unexpected needs rather than the initial, estimated ones. KIRP has 
had to be versatile in this regard. The original thought was that four Team Leads 
and 21 Risk Reduction Specialists would be needed in the state. These 
estimates were based on the days and hours that existing SSPs were operating 
at that time. Meeting with LHDs, however, HRI staff learned that those limited 
days and times were a function of insufficient manpower and resources. SSPs 
wanted and recognized the need for increased operating hours but had simply 
been unable to make it happen due to budget restrictions. Therefore, after 
accounting for more operational days and increased hours, it was found that 
much more personnel were needed. As of August 2020, HRI has hired 50 staff in 
40 counties. This includes twice as many team leads (eight vs. four) and other 
staff (42 vs. 21) as was anticipated, and hiring is not complete. Not all of the 
available KIRP funding was budgeted at the beginning, and that has been a 
pivotal factor in being able to amend and expand areas of HRI based on local 
needs. 
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The hiring process presented major obstacles. While a certain degree of 
complexity was anticipated, hiring turned out to be “surprisingly” complicated 
according to the HRI project director. Working with the Human Resources 
department of a very large organization came with its own challenges. Further, 
finding the right personnel in local areas sometimes took several postings and re-
postings. Often, a LHD had a candidate in mind, either from previous internships 
or other experiences. Matching available job descriptions with preferred 
candidates proved to be a difficulty that caused considerable delays in some 
areas. In the case of Northern Kentucky, for example, which was supposed to be 
the first area to come onboard, it took numerous postings, rewording/reworking 
positions, and a full year (June 2019-June 2020) to finally get fully staffed. 
Due to the difficultly in matching known candidates with job positions, new 
categories of positions were created. Instead of just Risk Reduction Specialists 
(RRS), a Risk Reduction Associate position was made available. This post 
requires less education and experience and allowed some LHDs to hire 
individuals they could not get approved for the RRS position. The local offices 
decide which positions they would like and can mix and match, as they deem 
necessary. 
The employment application system used by the University of Kentucky is 
particular and strict. Without prior experience and employment history worded 
just right, it was not recognized by the system. An estimated 75% of applicants 
had to go back into their applications and reword their experience and 
employment histories. They had to use different language in order to get hired 
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and paid commensurate with their actual experience. Even when the years or 
months of experience were counted appropriately, the salary offers were often 
not fair, in the eyes of HRI management. For example, 100 months versus 200 
months of experience yielded the same salary offer.  
After the hiring process, employee management was another area that 
had to be figured out. The logistics of supervision are tricky because embedded 
staff are technically UK employees, however the HRI core team knew that day-
to-day management should be handled locally. This includes time schedules and 
vacations or leave requests, among other issues. Policies for the division of 
supervision were developed with LHD staff and written up.  
Rolling out training for all staff was challenging. The HRI project director 
said that if she could do something differently, she would roll out hiring regionally. 
What happened was that different staff from all over the state came on board at 
the same time and the logistics of getting them all to a training was difficult and 
sometimes impossible due to travel. It would have been easier to schedule 
trainings by region. Lessons from this experience were applied almost 
immediately. Due to this experience, the Kentucky Finding Cases program, one 
of KIRP’s funded innovative, pilot programs, was rolled out differently (regionally 
rather than statewide) in order to onboard staff in a simpler and more cost-
effective manner. Overall, the HRI team was able to review and reflect upon 
issues in real-time as they arose, and they used the program flexibility to adapt 
and improve as necessary.  
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3.3.6 Harm Reduction Beyond Syringe Service Programs  
During the course of program development and early implementation, staff 
realized that some of the most vulnerable areas do not have SSPs or any form of 
harm reduction program. Therefore, there is a vital need for HRI presence in 
these places. Additionally, even in counties with such programs, many high-risk 
individuals do not utilize the onsite services. To address these needs, outreach 
became a necessary part of embedded staff job duties.  
Mobile units were requested by several counties and were provided by 
HRI. Other promising outreach venues are community-based organizations 
(CBOs). Local HRI staff have been exploring possibilities. Madison County 
decided to test out renting space within a free clinic in the community. Facilities 
such as shelters and food pantries may be other options. Partnering with CBOs 
is cheaper and safer than mobile units, and also faster to get under contract from 
a logistic standpoint.  
Outreach work beyond SSPs brings a myriad of logistical and evaluation 
issues with which to deal. It is imperative to keep track of where all testing is 
completed in order to evaluate whether it is an effective place to test. Again, the 
positivity rates will be reviewed, and if they are too low, it is an indication that 
staff may need to move to a new location. Thus, it is important to have a place to 
document the testing location during data collection. Talks were underway about 
whether there should be a separate section in REDCap for outreach at non-SSP 
sites. Also, there will be a separate evaluation plan for outreach locations, but it 
will be similar in that there will still be a quarterly report, with subsequent quarters 
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compared. It was noted that staff will need time to build rapport with community 
in outreach locations. Additionally, some counties may eventually be able to offer 
syringe exchange in these locations if they prove to be highly effective areas in 
which to connect with high-risk clients. In this way, these locations may also be a 
helpful strategy for LHDs that have issues integrating harm reduction services 
onsite at LHDs. 
Some counties wrote jail outreach into their HRI plans. Because the 
Health Resources and Services Administration (HRSA) recently changed the 
rules on allowing Ryan White funded services in jails, HRI may be a big help in 
allowing local programs to make an impact on incarcerated populations. Testing 
supplies purchased with HRI funds may be used for testing and education to 
incarcerated individuals. Theoretically, embedded staff are able to go into jails as 
long as the jail gives approval. As of December 2019, HRI was working with the 
Ryan White project officer to get official approval for staff to go into jails.   
 
3.3.7 State Plan for Ending the HIV Epidemic 
Since Kentucky is one of the priority jurisdictions for the Ending the HIV 
Epidemic (EHE) initiative, the state has been devising a plan. HRI has been a 
major stakeholder, working with other entities on this plan. The four pillars of the 
program are diagnose, treat, prevent, and respond. At the state level, there has 
been much discussion on how to respond to outbreaks such as the one in Scott 
County, Indiana or ones that nearby HIV clusters may foreshadow. Knowing that 
the state has very limited resources, all potential, available assets are being 
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evaluated. HRI will play a significant role in the state’s EHE strategy. Response 
plans are being written to mobilize local HRI staff and/or deploy staff to the 
county where an outbreak is occurring in the case that one does. The HRI set up 
gives a good framework for response. 
 
3.3.8 SSP CLIENT EXPERIENCES 
Although it is a Best Practice,133,160 in reality, SSP operation is often not 
informed by those who use the services. The HRI DPH administrator carried out 
a series of interviews with clients of SSPs around the state during August 2019, 
in order to solicit information from individuals who have been utilizing the 
services.161 The administrator is a former DPH employee familiar with the inner 
workings and felt that client voices are not always well represented in program 
development and improvement. For HRI, being familiar with the context of a 
client’s drug use is essential for informing the types of services and supplies that 
need to be available at SSPs and harm reduction programs. The administrator 
was surprised by the uniqueness of each client’s situation and the differences 
found among the various counties, populations, and programs. He learned that 
there are no experts on drug use experience except for the clients themselves 
and that expertise only extends to their own individual reality and not anyone 
else’s. Nonetheless, common themes did emerge in the course of these 
discussions. 
During the interviews, he asked about drug use including the drug(s) of 
choice, frequency and route of consumption, fentanyl, and overdose experience, 
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as well as barriers and challenges clients face. Many clients were very open 
about their experiences and shared information readily. Early on in the interview 
process, valuable information and suggestions surfaced that led to changes in 
program operations. For example, the information that the consumption of 
methamphetamines causes the blood to thicken came up. This makes it difficult 
to get a good sample when testing for infectious disease. Therefore, programs 
were given approval to buy water bottles and snacks in order to mitigate this 
issue.  
For the most part, injecting seems to be the most common way to 
consume drugs in these areas. Even meth is no longer smoked. Clients stated 
that everyone ‘shoots it up’ now because it ‘hits harder’ and produces a better 
high. One exception was a county where clients said that everyone there is still 
using Percocet because there is a doctor who is selling them locally, and he 
makes ‘a killing’ doing it. The Percocet is crushed and snorted. Therefore, in this 
area SSP education should include safer snorting information and ideally, safer 
snorting kits.  
Clients spoke about side effects and characteristics of their drug use. 
They stated that certain drugs induce a voracious sexual appetite, thus they 
engage in frequent sexual acts while under the influence. This is particularly 
concerning for infectious disease transmission and stresses the importance of 
family planning for women. Client experiences with fentanyl were discussed as 
well. They stated that fentanyl is everywhere, and since it speeds up the high, 
clients must buy more drugs and use more often. This leads to a high frequency 
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of injecting. Therefore, in SSPs where there is a limit on the number of syringes 
that can be given, it will likely not be enough. The Best Practice is a needs-based 
model. 
Most participants reported prior overdoses. In fact, an overdose occurred 
while the HRI DPH administrator was onsite interviewing. Some clients reported 
having naloxone, and some used with other people around as an overdose 
safeguard, but many did not.  
The HRI DPH Administrator asked clients about their history of getting 
tested for infectious disease. Most had been tested for HCV or simply assumed 
they must have it. There was a very fatalistic mindset when it came to HCV, 
however, no one wanted to talk about HIV, as there is still so much stigma 
surrounding it in many areas, particularly rural ones. This is important for the 
health educators and risk reduction specialists at SSPs. One SSP used to do HIV 
testing one day a month only, but now offers it every day since the HRI staff was 
hired. When it was held one day per month, no one showed up for testing, largely 
due to stigma since everyone knew those were HIV testing days. 
While mainly using now to prevent dopesickness and to be able to 
function, many clients stated that they initially used drugs as a way of self-
medicating. Clients spoke of difficult childhoods and various types of trauma they 
had experienced throughout their lives. One client stated, “It takes away the 
pain”. Another stated it was to lessen their stress.  
The HRI DPH administrator asked clients why others they know do not 
use SSPs. Their answers included not wanting their names in a system, being 
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afraid of law enforcement, being too high to come in, having a day job that 
conflicts with SSP hours of operation, fear of losing their job, being embarrassed, 
and lack of transportation. Common challenges they reported facing were living 
situations (often homeless or precariously housed, frequent eviction), 
employment, and transportation issues.  
Understanding client situations, experiences, challenges, and motivations 
is an important dimension. It is critical for program development, implementation, 
and monitoring that staff have a contextualized understanding of the target 
population in order to have the most effective program that does the right things 
(provides relevant and necessary services) and identifies and reaches the right 
people (those at most risk). In addition, the HRI core team knew they needed to 
have a grasp of the environment and mindset of LHDs and other sites where they 
wished to embed HRI staff in order to market the program to them and organize 
the services accordingly. 
 
3.3.9 Local Health Department Staff Perspectives 
Some important assumptions in the program logic are that local staff will 
be open to HRI participation and that staff viewpoints, beliefs, and perspectives 
will not negatively affect service provision. For HRI management, interactions 
with and anecdotes about LHD staff revealed some insight into these 
assumptions.  
Early on, when HRI staff first started meeting with local health 
departments, one HRI staff member noted that program was initially met with 
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uncertainty because LHDs were used to the state “taking things away from them” 
due to budget restraints, policy changes, or resource reallocation. However, by 
the end of each meeting, the KIRP staff stated that LHD personnel felt like it was 
“Christmas in July”. The LHDs were able to see that there were many resources 
offered with very few strings attached. The initial hesitancy and skepticism were 
quickly and easily assuaged.  
Another issue encountered was that local staff had varying opinions on 
SSPs, harm reduction, and SSP clients. When health departments first started 
offering harm reduction services, some veteran HD staff felt like those services 
were taking away from what they thought local health departments were 
supposed to be doing, such as reproductive health services for women and 
preventative health for children. However, with the passing of the Affordable Care 
Act and expanded insurance coverage, patients had more options and were able 
to access those services elsewhere. Many people have primary care providers 
for the first time in their lives and do not have to rely on local health departments 
for their care.  
Additionally, it was found that some LHD staff had negative perceptions of 
people who use drugs (PWUD), sometimes referring to them as “those people”. 
Some staff did not agree with the concept or provision of harm reduction 
services. Anecdotally, it was felt that these negative perceptions espoused by 
staff were affecting service provision and the way SSP clients were being 
treated. Some LHD staff had been working at HDs since before SSP or harm 
reduction work began and were asked to engage in harm reduction work despite 
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their opposition to it. However, to keep their job, it was something these staff felt 
they were forced to do despite the fact that they “didn’t sign up for it”. In cases 
where staff felt this way, HRI was particularly needed and welcomed as those 
staff members no longer had to engage in services that they did not agree with.  
Now, it is a win-win situation with HRI providing the resources for new, dedicated 
staff that are passionate about harm reduction and the clients who use the 
services. Those staffing SSPs are now people who specifically want to do that 
work versus people who are ‘forced’ to do that work. 
There were existing staff at some SSPs who were very passionate about 
their client population. Some were peers and some simply had compassion and 
empathy for their clients. These staff were pivotal in offering insight and 
suggestions for program development and improvement. They were quick to 
point out barriers they knew their clients faced and helpful ideas for ways SSPs 
can best serve the community. For example, they knew many of their clients deal 
with food insecurity and often come hungry. Many suggested food assistance 
and being able to keep snacks on hand. These staff were familiar with their 
communities and were able to point out places where outreach and mobile units 
could reach others in need. These staff were also familiar with the health status 
of those they serve, such as the uptick in syphilis cases locally. This trend was 
also being seen in state-wide data and was one reason why rapid syphilis testing 
is being explored. These staff members were vital to SSPs before HRI and 
continue to be now.  
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3.4 Monitoring 
After initial implementation, monitoring occurs in order to ensure that 
program activities are being carried out faithfully and competently.18 Observation 
and follow-up interviews are ways to evaluate the program well into 
implementation.  
 
3.4.1 Monitoring: Ongoing Activities 
In order to maintain relevancy and sustainability, ongoing monitoring of 
programs must take place. HRI management frequently solicits feedback from 
embedded staff and is highly responsive to expressed needs. This was illustrated 
early on when core staff responded to voiced concerns by putting an extensive 
amount of time and effort into making an adequate data collection tool a priority 
and a reality. The KIRP project director states that data was one of the leading 
complaints they have received from the field. Both the hassle of inputting and 
recording SSP data in a non-user-friendly system and the inaccessibility of data 
from the state were concerns that SSPs had. After the revamped REDCap came 
out and local HRI staff were hired, more sites began using the system. HRI is still 
working to convince others to adopt REDCap in their practice. 
  Through use of a more uniform system, HRI and individual SSPs can 
access their data easily and immediately. The management staff will continue to 
have regular data meetings to review the previous month’s REDCap data. In this 
way, monitoring of program activities is consistent. In addition to REDCap data 
review, quarterly reports and frequent discussions with local staff occur. 
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Management wants to keep staff at different locations communicating with each 
other, sharing challenges and successes.  
There has been an ongoing conversation surrounding whether completely 
integrated services or separate, defined hours for syringe exchange at local 
health departments is better. In general, the best practice is to have integrated 
services, and around one-quarter of programs in Kentucky are integrated. 
However, sometimes the SSP client may not want to be in with the general 
population. Clients have stated that patients in the LHD for medical or other 
services know or assume the reason that the clients are there, and it contributes 
to an atmosphere of stigma. In these cases, the clients prefer separate hours or 
a separate area for exchange services. KIRP has found that the setup of the LHD 
affects which model works better. HRI will attempt to look for ways to address 
stigma through education and anti-stigma campaigns. Mobile units allow a 
separate, safe place so that PWID do not have to go LHDs to access SSPs. The 
staff, both management and embedded, continue to seek ways to improve the 
program in any way they can.  
 
3.4.2 Best Practices Evaluation Tool 
In 2019, the National Alliance of State and Territorial AIDS Directors 
(NASTAD) developed a Program Evaluation Tool for the CDC that measures an 
organization’s level of Best Practices as applied to SSPs.162 Its design is based 
on a Stages of Change Model. It includes five stages ranging from “Not a current 
practice and not yet in discussions to change” to “Consistently employ this policy 
or practice” (See Appendix G). With the aim to reach the highest level of national 
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best practices standards possible, Harm Reduction Initiative staff chose to 
incorporate the tool into their work. Though some sites will never reach full 
potential on this scale due to restrictions of local regulations, it gives HRI 
administration an idea of the direction in which a program is heading. For 
baseline data, they decided that embedded HRI staff will complete the survey 
when they first begin working at their site and will reassess annually. The KIRP 
director of evaluation and outcomes digitized the survey tool into an online form 
with a link to be sent via email to RRSs to fill out (See Figure 3.11). In this way, 
real time data may be captured without the need to input or compile further data. 
This online evaluation form was piloted with the first RRS who came on board 
and was revised based on recommended changes and further discussion. One 
major change was the addition of a comments box after every question. The 
RRS wanted the opportunity to explain the situation with respect to each 
individual question. HRI administrative staff decided that this would be valuable, 
qualitative data that can be used to inform possible change and see where more 
attention or resources are needed. 
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Figure 3.11: HRI Adaptation of NASTAD Program Evaluation Tool (page 1) 
 
 
 
3.4.3 Further Concerns, Future Issues  
There are intended outcomes of the Harm Reduction Initiative, that, for 
now, will remain unmeasured: lower substance use disorder (SUD) rate, 
decrease in overdose incidence and death, decrease in syringe litter, increase in 
community support for harm reduction programs, and lower rates of stigma in 
communities and healthcare facilities. As the initiative grows and local programs 
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gain capacity, HRI will look at adjusting targets and adding goals for official 
measurement. 
Over the past few years, there has finally been an influx of funding and 
resources into the state to address the opioid epidemic. One potential issue of 
the many public health and grant-funded programs aimed at combatting drug use 
issues is whether the HRI impact evaluation results will be confounded by other 
programs’ activities. HRI management staff believes this is probably not going to 
be a problem as each program is largely measuring different things. For 
example, the Healing Communities program is focused on overdose and 
overdose death prevention163 and others on HCV elimination.164 Some state 
programs are looking at substance abuse and mental health treatment 
services.165 HRI will be focusing on HIV rates and linkage to care. Furthermore, 
one of the functions of the HRI DPH administrator is to monitor other programs 
operating in the state in order to prevent duplicative efforts.  
If HRI program activities are done well and carried out to the fullest extent 
possible, an initial increase in HIV cases is expected as previously undiagnosed 
individuals learn their status. The state is currently not prepared for an increased 
population of newly diagnosed. At the time data was being gathered for this 
study, disease intervention specialist (DIS) work was almost non-existent for new 
HIV cases. It was still somewhat robust for syphilis, however, so HRI felt 
comfortable piloting rapid syphilis testing. Investigative and contact tracing work 
for both HIV and HCV is a challenge that is on the radar of both local and state 
entities. 
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3.4.4 Data, Surveillance, and Response Capacity of the State 
The current capacity of the state frequently came up in conversation 
during meetings and interviews. Data infrastructure at the state level is 
suboptimal and continues to be a limiting factor in programs and activities that 
require robust surveillance. Furthermore, it was generally agreed upon by the 
various stakeholders that the state had limited capacity to detect and respond to 
potential infectious disease health threats. Due to the inadequate data collection 
and surveillance, the identification of problem areas or clusters of infectious 
disease is delayed and restricted. For example, local entities recently found a 
potential HIV cluster in one Kentucky health district, but the state could not 
determine the origin. Local public health officials theorized it could have 
originated from a nearby military base. Cases such as these are noticed locally 
but not caught by the state surveillance system. Likewise, Ryan White clinics 
were anecdotally seeing unprecedented increases in newly diagnosed HIV 
patients whose risk factor was injection drug use well before the state could 
respond or preempt further infections by offering assistance to local entities. It 
was years later before any meaningful funding or response materialized, and this 
was largely from federal channels.  
It is imperative to know and understand the capacity of state-level offices 
to respond to emerging public health crises. When insufficiencies are found, 
programs can help fill in the gaps. How KIRP can assist the state in data, 
surveillance, and response is an ongoing conversation. As HRI is more fully 
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implemented and increases in strength and efficiency, the core team hopes that 
HRI data can help provide an infrastructure in the state for improved data and 
surveillance and lead to more reliable estimates. They continue to work toward 
this goal. 
In addition to state-level deficiencies, gaps exist on a community and 
institutional level. Even when an adequate level of testing and positivity rates is 
achieved, there are challenges that will be faced by embedded HRI staff and 
clients alike. HRI will have to provide linkage to care. As is, there are limited 
options for referring patients to treatment for HIV, HCV, PreP, and substance 
use. Clients face barriers in accessing services due to limited availability 
particularly in rural areas, provider shortages and lack of training in existing 
providers, issues of discrimination, and insufficient cultural competence when 
working with special populations such as sexual minorities.  
Other areas of KIRP are designed to work on many of those issues, 
including provider education to both increase the quality and number of providers 
offering treatment for relevant conditions and decrease stigma, unconscious or 
conscious bias, and assumptions or misunderstandings frequently held regarding 
various patient populations. 
Additionally, taking into account the numerous, adamant concerns of LHD 
staff and SSP clients regarding law enforcement interference, there are plans to 
address misconceptions and bias in police agencies. The AIDS Education & 
Training Center (AETC), another Ryan White and KIRP founded program, plans 
to launch education for law enforcement in the future. A recent study on barriers 
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to using new needles in Rural Appalachia found that the most frequently reported 
barrier was law enforcement. The researchers suggested reframing education, 
engagement, and advocacy efforts to align goals with the occupational safety of 
law enforcement in the hope of improving police perception of SSPs.49 
Something HRI is excited about is the hiring of a retired police officer who 
understands the importance and necessity of harm reduction services for the 
SSP in one rural Kentucky county.166 This individual is helping the core team to 
better understand the law enforcement perspective, and he has been speaking to 
his acquaintances still in law enforcement to engage and educate them on harm 
reduction as well.  
 
3.4.5 Comprehensive Approach 
The HRI, having been thoroughly considered, organized, and 
appropriately laid out, was well situated for implementation. The program 
addresses all six areas that an adequately comprehensive approach to the opioid 
crisis should include: leadership; partnership/collaboration, 
epidemiology/surveillance; education/prevention, treatment/recovery, and harm 
reduction/overdose prevention.86 The Harm Reduction Initiative works in 
collaboration with the top public health leadership in Kentucky, partners with 
LHDs and other organizations throughout the state, places high priority on and 
builds capacity for adequate data collection leading to improved surveillance, 
focuses on educating and screening individuals for prevention of morbidity, 
assists and advocates for referrals to treatment and recovery, and emphasizes 
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harm reduction including supplies provision and information on overdose 
prevention.  
Overall, clarificative, interactive, and monitoring evaluation of the HRI 
reveal a strongly developed, thoughtfully implemented program that is 
continuously monitored for quality and improvement. It is poised to provide a 
needed service with good results and, in fact, is already seeing progress and 
opportunities for even greater success. 
Table 3.4: Clarificative, Interactive, & Monitoring Data Coding 
Open Coding (Initial concepts and categories) 
Axial (Refined 
concepts and 
categories) 
Selective 
Coding- Core 
Categories 
-Multiple meetings to refine iterations of what HRI 
should accomplish 
-How and what to measure to determine success 
-Determining motivated yet achievable standards 
Establishing 
Goals/ Objectives 
Clarificative 
(Development 
Process) 
-Press conference 
-Press Releases/news media 
-Presented HRI at 2019 Harm Reduction Summit 
-BLOCK HIV/HCV 2019 
-AETC Conferences 
-Personal Contact 
Dissemination/ 
diffusion of 
program 
awareness 
-Logic model development: establishing/identifying 
inputs, outputs, outcomes, assumptions, external 
factors 
-LogFrame Matrix completed- activities, output, results, 
purpose, goal; determining process, progress toward 
goal 
Program 
Description 
-Did not budget all funding initially; left room for 
expansion based on needs 
-HRI is responsive to funding other allowable areas in 
order to offset cost of syringes or any non-allowable 
injection supplies 
Using flexibility to 
address funding 
limitations 
Interactive (Early 
implementation)   
-Poor existing data collection tool 
-Challenge of uniformity for reporting/data collection 
from different sites with different practices/systems 
-Funding limitations (RW allowable only) 
Limitations 
-Bureaucracy/Red tape leading to delays (contracts) 
-State leadership changes 
-Issues with data collection system 
Challenges 
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-Data collection tool revamped 
-Input from tool users sought before, during, and after 
improvements  
-Need to establish reliable baseline data 
Data 
Collection/Surveill
ance 
-Interviewing SSP clients 
-Utilization of NASTAD Best Practices Evaluation Tool 
-Seeks to address problems laid out in Problem Tree 
Analysis 
Ensuring 
evidence-
based/best 
practices 
-Figuring out structure of employee management: local 
vs. UK 
-Regular meetings 
-Organization: Gantt chart/Kanban system 
-Reporting requirements for local sites 
-HRI staff review data on regular basis 
Logistic Concerns 
-Team represents diverse and relevant knowledge and 
experience 
-Seeks out further information/expertise on topics they 
believe to be important to program (Invited prof to share 
research on SSP/PWUD, Spoke to software developer 
for data collection tool options) 
-They do not assume they have all the answers, thus 
refuse to listen to others 
-Interviews with PWUD at SSPs 
-Input sought from SSP staff on data collection needs 
-Feedback is solicited from HRI staff in the field 
regarding any new policies and procedures.  
Core staff 
behavior that 
leads to success 
-Organizational chart expansion; many more staff than 
anticipated needed  
-Added additional positions to accommodate different 
educational levels 
- Flexibility with funding for allowable services in order 
to offset SSPs’ costs for non-allowable items 
Adaptations 
Made After 
Review/ 
Reflection 
-Positivity rate will be the testing metric used to ensure 
high risk individuals are being targeted 
-SSP staff realized there were many high risk 
individuals in the community not utilizing SSPs, 
therefore, mobile units, outreach, and services offered 
at other CBOs were set up.  
-Working with Ryan White project officer to get approval 
to go into jails 
-Ongoing conversations about integrated vs. separate 
hours for SSP at LHDs 
Ensuring Target 
Populations are 
reached 
-Bureaucracy/Red tape leading to delays (contracts) 
-Completely novel program- developing everything from 
the ground up 
-Hiring “surprisingly” complicated 
-Training roll out was challenging; would do differently if 
could 
-Balance between standardization and diverse local 
needs 
Challenges 
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-Ensure all hired staff are fully trained 
-Supplies purchased with HRI funds may be used in 
jails 
-Assisting with state Ending the HIV Epidemic plan  
Ensuring 
resources/ needs 
met 
-Initial skepticism of KIRP 
-Opinions on harm reduction 
-Bias towards PWUD 
-Staff passionate about this population/helping others 
LHD/SSP Staff 
Perceptions 
-Interviews with SSP clients revealed information, 
concerns helpful for improvement of service provision  
-Drug use, overdose, trauma, infectious disease testing, 
barriers/challenges 
Target Population 
Perspectives 
-HRI Management is highly responsive to expressed 
needs 
-Regular reporting required from HRI SSP staff 
-Quarterly staff meetings 
-Encourage HRI staff from different counties to 
communicate/collaborate with each other (staff 
meetings, email lists, etc.) 
-Feedback solicited from HRI staff in the field for new 
policies and procedures 
-NASTAD SSP Best Practices Tool 
-HRI meets all 6 requirements of a comprehensive 
response 
Ensuring ongoing 
quality  
Monitoring (On-
going) 
-Intended and Unintended consequences  
-State capacity: ability to follow-up/deal with positive 
cases; data infrastructure 
-Community/institutional capacity to handle new 
diagnoses 
-Accurate impact results  
-Ongoing conversations about integrated vs. separate 
hours for SSP at LHDs 
-Education for law enforcement  
Ongoing/Future 
Concerns 
123 
4. DISCUSSION 
4.1 Findings and Implications 
Formative program evaluation provided an efficient framework in which to 
assess the KIRP Harm Reduction Initiative. Being in its development infancy and, 
soon after, initial stages of implementation, the program was a prime candidate 
for this type of evaluation. Furthermore, Grounded Theory principles allowed 
answers to relevant evaluation questions to arise fully and naturally, as often 
happens in qualitative research. More contextualized dimensions are uncovered 
that may have otherwise been overlooked in a traditional, quantitative survey or 
interview. Evaluation results from the four formative categories, proactive, 
clarificative, interactive, and monitoring, are presented here.  
 
4.1.1 Proactive  
Proactive research seeks to understand or clarify the need for a project. A 
literature review substantiated the identified needs within the state in regards to 
infectious disease consequences of drug use. It also helped to lay out the 
landscape of causes and effects in order to better understand what the state is 
up against and how best to address the issues. This was illustrated in Problem 
and Solution Trees. Stakeholder Analysis assessed those involved and 
connected to the program.  
The rates of HIV, HCV, and complications secondary to drug use (sepsis, 
abscesses, osteomyelitis, and endocarditis) and high-risk behaviors make 
Kentucky’s population vulnerable to widespread and long-term consequences 
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that can devastate generations of its residents. There are practices and policies 
that can mitigate the effects, such as harm reduction principles, along with 
infectious disease testing and linkage to care. Medication for treatment, cures, 
and prophylaxis exist to control the spread of disease. 
In assessing local needs, health department personnel described the 
situations within their area and barriers they face. Staff and funding are limited to 
non-existent for certain programs. They have issues collecting and submitting 
data to the state due to cumbersome and outdated tools, they do not have 
access to sufficient surveillance data with which to effectively monitor their public 
health status, and they have difficulty reaching and providing services for certain 
populations due to immense barriers faced by those individuals, including 
incarceration. Local public health staff also often face opposition from law 
enforcement and governmental officials in their area when trying to provide care 
and services to PWUD, especially harm reduction services. LHD personnel also 
expressed fear due to lack of information, training, and capacity to respond to 
potential outbreaks in their community. 
 
4.1.2 Clarificative 
The objective of the clarificative category of formative program evaluation 
is to make the theory of change that the project is based on clear. Tools such as 
logic models and LogFrame Matrices lay out the program logic and theory in 
easy to understand depictions. These tools were developed for the HRI and lay 
out the inputs, outputs, outcomes, assumptions, and external factors associated 
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with the program as well as the logical progression from activities through output, 
results, and purpose, to the end goal.  
 
4.1.3 Interactive 
Interactive assessment occurs early in implementation and is used to 
improve the program’s design. Aspects of HRI management, organization, and 
implementation strategy and practices were analyzed. A vital part of the program 
rollout was the development and improvement of the data collection tool which is 
central to activity monitoring and goal evaluation. Additionally, managing the 
balance between state-wide standardization for quality assurance and local 
needs and nuances is critical for this innovative and much-needed program. 
HRI’s ability to review and reflect upon circumstances and adapt where 
necessary was important for effectiveness and relevancy. It became apparent 
that outreach work would be a vital component to access those in most need. 
Additionally, due to HRI’s setup and the fact that it is spread throughout the state, 
it will be a part of Kentucky’s official plan to End the HIV Epidemic. HRI solicited 
input from SSP clients in order to implement practices that are appropriate for 
actual needs of consumers and took into account perspectives of HD and SSP 
staff to address concerns.  
 
4.1.4 Monitoring 
Further into implementation, monitoring evaluation is used to ensure that 
activities are being delivered efficiently and effectively. HRI management utilized 
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frequent feedback from embedded staff to learn about and address issues. The 
core team has been shown to be highly responsive to staff needs. They have 
also leveraged existing strengths of employees while providing opportunities to 
support areas where improvement is needed. Furthermore, they continually look 
for ways to keep the program operating at the highest standard possible. They 
have implemented a national Best Practices Evaluation Tool for all their sites. In 
addition, HRI management has been looking into and assessing the capacity of 
the state to provide data surveillance and outbreak response when needed. HRI 
is in ongoing conversations to support these efforts.  
 
4.1.5 Overall 
The methodology and results revealed a program that was necessary, well 
thought out, carefully deployed, consistently checked for areas of improvement 
and success, and modified as necessary. Such study of public health programs 
is fundamental to ensure effectiveness and continued relevance in a time and 
place where public health programming and funding is scarce and often 
threatened. 
 
4.1.6 Policy and Management Implications 
Investigators argue that research evidence has a potentially significant 
impact on policy change. They state that advocates should incorporate such 
evidence into efforts to establish public health programs.152 Opponents often use 
(or misuse) data in opposition of certain policies, particularly controversial ones 
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such as SSPs. However, public health professionals may miss opportunities by 
not using research to counterbalance erroneous or misleading claims.152  
We have seen the implications for policies that allow or prohibit syringe 
exchange and other harm reduction services. Syringe exchange was illegal in 
Indiana when the Scott County outbreak occurred. It worsened significantly 
before emergency orders finally allowed SSPs to operate.58 We also know after 
three decades of documented research that SSPs reduce infectious disease 
transmission, do not increase crime or drug use, and lead to less syringe litter in 
the community.133  
State and local infectious disease testing policies play a crucial role when 
it comes to detecting and mitigating outbreaks. Funding and data collection are 
pivotal factors in these policies. Proper and adequate surveillance must be in 
place to ensure that disease clusters do not turn into the next epidemic.  
Management practices of harm reduction programs lead to either efficacy 
or failure, which shapes the public perception of these programs. This perception 
will determine the support or opposition for the continuance of such programs or 
expansion of services. With fierce competition for scarce public health dollars, 
assumptions of efficacy are not sufficient,167 and success must be shown through 
evaluation.  
 
4.1.7 Utilization-Focused Evaluation 
The target of good evaluation should be effective utilization.168 The results 
of this study are intended to be used by the HRI management staff to continue 
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improvement activities and strive for the highest-quality and most relevant 
programming possible. This report and all findings will be shared with the core 
KIRP staff. The evaluator will be available for any questions or clarification the 
staff may need. 
 
4.2 Limitations 
For this project, several strategies sometimes employed in qualitative 
analysis were not feasible including peer collaboration in data collection and 
coding. Video or audio recording was not possible, therefore meetings and 
interviews were not transcribed verbatim, and coding was done manually. 
Though detailed field notes were taken, it is possible that some items were 
missed during meetings. Furthermore, with more time and manpower to make it 
feasible, in-depth interviewing of additional HRI team members may have added 
to the research. 
 
4.3 Recommendations 
This section of the report provides recommendations for the program, 
based on the information collected and analyzed. Some represent intense, long-
term commitments; others are far simpler and less time-involved. These 
recommendations are not ordered by priority or feasibility. They are largely 
designed to evoke a broader conversation among stakeholders to work toward 
achieving KIRP’s highest potential. The recommendations are grouped by: 
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General Programmatic Issues, Service Expansion, Local Needs Assessment, 
Client Input, and Education/Advocacy.  
 
4.3.1 General Programmatic Issues 
Based on the real and critical needs identified, and the established 
capability of this program to address them, HRI should remain in operation and 
expand to other areas of the state. Existing funds should continue to be used for 
this endeavor, as they are, to date, plentiful and versatile enough to allow the 
program to be effective. One caveat is that it may be beneficial to supplement 
with some additional non-Ryan White funding to address gaps that arise due to 
non-allowable services (needles/syringes, HCV testing incentives). 
HRI core staff should continue their management style of seeking out 
further expertise and knowledge when presented with new situations as it 
ensures any gaps in understanding are filled and that the staff become and 
remain as competent as possible. This will ensure they stay up to date on current 
or evolving trends and they are able to make the most informed decisions 
possible. 
In the absence of real-time surveillance data in the state, management 
and embedded staff should continue to foster their consistent and instantaneous 
internal communication about happenings in their local areas as a way of forming 
a real-time alert system for important events, such as potential outbreaks, mass 
overdose, which may indicate contaminated product in the area, or other sentinel 
events.  
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Part of KIRP’s mission is to eliminate HIV infections in the state, and in 
terms of goal setting, a general statement of an anticipated decline of HIV and 
Hepatitis C rates within five years has been put forth. A discussion on whether to 
set specific targets for the rate declines may need to occur. This will likely be 
predicated on the ability to establish an adequate data and surveillance 
infrastructure which can produce accurate baseline figures. A practical and 
functional action would be to align goals with national strategies such as those 
from the Ending the HIV Epidemic and National Viral Hepatitis Action Plan.  
 
4.3.2 Service Expansion 
LHD staff acknowledged that there are high-risk populations who do not 
access SSPs. HRI should continue to build capacity for expanding services 
beyond SSPs to reach individuals with barriers that prevent them from physically 
coming to these programs.  
The lack of services or access to jails was a highly voiced concern given 
the sheer numbers of county residents that cycle in and out of detention centers 
on a regular basis. This is a high-risk population and an easy point of access 
given they are a “captive audience”. Infectious disease testing, linkage to care, 
treatment initiation, MAT, PreP, and vaccinations are services that could and 
should be offered in county detention centers.   
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4.3.3 Local Needs Assessment 
Identifying local needs was essential in determining what relevant services 
should be offered by HRI. It is important that the program continue to assess 
local needs as they change over time, particularly if previously identified needs 
are being effectively addressed. Periodic local needs assessments should be 
built into program operations. 
 
4.3.4 Consumer Input 
Service provision should be informed by those who use the services. HRI 
should seek regular input from clients on the quality and value of services 
offered. Staff should continue to follow-up and check in with SSP/HRP clients to 
evaluate their drug use status, practices, routes of consumption, and type of 
substances consumed in order to keep the existing services and activities as 
relevant as possible.  
Furthermore, beyond inquiring about drug use behavior, staff should ask 
about challenges clients face accessing SSPs, getting tested, and engaging in 
care. Find out what the barriers are when clients or those they know are not able 
to use SSPs. Then, look for ways to address the issues. This will require 
accumulating knowledge of not just local medical referral locations but social 
service agencies as well. SSP clients have indicated housing instability, 
employment, and transportation are major issues they face. This will affect their 
ability to get tested, linked to care, and engage in treatment options. HRI needs 
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to be positioned to take into account these structural vulnerabilities in order to 
adequately achieve their objectives.  
 
4.3.5 Education/Advocacy 
Embedded HRI staff should advocate within their local communities to 
ensure that SSP best practices can be implemented; including needs based 
exchange for needles and syringes instead of one-for-one. This will also allow 
secondary exchanging to be possible, thereby indirectly accessing individuals 
who do not physically come to the SSP. Furthermore, embedded HRI staff 
should continue to identify and advocate for SSPs/HRPs in areas where they are 
needed but still lacking. 
Discussions with some LHD staff prior to HRI embedding staff revealed 
that some local employees espoused negative and stigmatizing views towards 
PWUD and harm reduction practices. In addition to hiring the right staff, HRI 
should ensure adequate training on anti-stigma topics including client-centered 
and recovery-positive language, to help reduce an unintentionally stigmatizing or 
unconsciously biased environment.  
Since it was such a heavily voiced local concern, HRI should continue to 
seek ways to address law enforcement interference in SSP operations. Progress 
has been made with the hiring of former law enforcement personnel. KIRP plans 
to implement an AETC educational series for law enforcement should go forward. 
Staff should seek further ways to engage local law enforcement.   
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HRI should continue to collaborate with the state and other entities toward 
an adequate and robust data and surveillance system, as this is imperative to be 
able to identify and respond to public health concerns. 
A last, more aspirational recommendation will likely involve state-level 
authorization and will depend upon the national climate at the time. HRI can be 
helpful in advocating for and promoting supervised injection facilities. Lessons 
learned from embracing and encouraging SSPs can be applied to the current 
debate over these sites. Supervised injection facilities, also called overdose 
prevention sites, harm reduction sites, safe injection facilities, or safe 
consumption sites, are secure and hygienic spaces where individuals can bring 
and inject their substances under medical supervision.169-171 Among advocates, 
the preferred name is often overdose prevention site (OPS) as it draws attention 
to the primary reason for the facilities (to reduce overdose mortality), and it is 
less stigmatizing.171  
Although common in Canada, Australia, and Europe, there has not been a 
sanctioned site opened in the United States. Organizations in several states 
(California, Colorado, Washington, Oregon, New York, Missouri, Wisconsin, 
Maine, Vermont, Massachusetts, and Maryland) have considered, attempted, or 
come close to opening one only to be blocked by threatened or actual legal 
action.170-172 At the end of 2019, a federal judge ruled that a Philadelphia 
organization’s plans to go ahead with an OPS was not against the law.172 The 
organization is based in the neighborhood with the highest overdose mortality in 
the city with highest overdose mortality among all large cities in the U.S.171 A 
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peer-reviewed and published research study found that 90% of neighborhood 
residents and more than 60% of local business owners were in favor of the site 
opening.171  
The American Medical Association and other health organizations are in 
favor of OPS.170 Recently released research on an unnamed, unsanctioned site 
in the U.S. shows no overdose deaths from more than 10,000 injection events.173 
Studies of sites elsewhere in the world illustrate their efficacy in the prevention of 
overdose, infectious disease, and mortality.169,170,174 They have been shown to 
reduce the incidence of public injecting and subsequent syringe litter in the 
community.170 Like SSPs, these sites also increase the likelihood that clients 
seek and enter addiction treatment and help them access needed health and 
social services.170,173   
Despite the myriad of research studies touting the social and health 
benefits of such facilities, morality opinions and misconceptions keep laws and 
regulations in place that discourage the opening of these facilities.170 Sooner 
rather than later society should embrace evidence-based practices that save 
lives and give individuals suffering from addiction the opportunity to overcome or 
cope with major obstacles they face. We know that the causes of such afflictions 
are deep and multifaceted, and while we find ways to address those, we need 
measures to keep people alive, safe, and able to take advantage of second 
chances.   
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4.4 Conclusions 
COVID-19 with its sudden, massive, and unprecedented effects has upset 
all areas of life, and public health capacity in particular has been shocked and 
overwhelmed. Many personnel and vast resources have been redirected to fight 
the most pressing health concerns at hand. People who inject drugs are 
particularly vulnerable to other outbreaks because of a myriad of risk factors 
including comorbidities, homelessness and housing instability, and 
stigmatization, among others.175 Testing for infectious disease has decreased.176 
For those working in harm reduction and infectious disease prevention, there are 
fears that recent progress made could be entirely wiped out.176 On the other 
hand, this pandemic experience may teach us lessons applicable to various 
areas of public health. Real-time data and surveillance that is useful for near 
immediate decision-making and mitigation efforts has been one of the hallmarks 
of COVID-19 monitoring. “Within a few weeks from the time the first cases were 
diagnosed in Wuhan, China, anyone with an Internet connection could monitor 
the spread and effects of COVID-19. More importantly, elected leaders, 
scientists, and health care workers can see these data and use them to inform 
their responses and their choices of interventions in real time.”177 Additionally, 
this pandemic could lead to more robust disease investigation and contact 
tracing work for other infectious diseases, as novel methods have emerged in 
many countries.178-180 This unprecedented occurrence will impact HRI operations 
and may affect its ability to achieve its goals. Conversely, necessity may force 
further creative modification to meet challenges head on. Perhaps the major 
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lesson learned is that program flexibility and adaptation are more important than 
ever. 
Kentucky is a predominantly white state181 and the opioid and injection 
drug use crisis is often characterized as an issue largely affecting white 
populations. However, communities of color have been disproportionately 
affected in a variety of ways.182,183 Communities of color are overrepresented in 
rates and complications of HIV184 and viral hepatitis.185 The public health 
inequities among communities of color and lack of attention to the issue have 
long been concerning, particularly considering intersectional stigma and 
discrimination,76,186-189 as well as structural vulnerabilities.190,191 Kentucky does 
not have an insignificant population of people of color, and that proportion is not 
decreasing.181 During the course of meetings and interviews, discussion 
regarding communities of color did not occur. The fact that it did not come up in 
conversation may or may not indicate an oversight. However, it is necessary to 
purposefully ensure that these populations are not being overlooked. These 
considerations are important for outreach, staff hiring, and service provision, 
particularly in light of historic mistrust of medical and other institutions among 
communities of color.192-197  
Research as well as SSP client interviews that HRI conducted reveal the 
extent that the drug use crisis is an epidemic of despair.161,198-200 In interviews 
and conversation, Kentucky SSP clients regularly stated that they used drugs to 
self-medicate for emotional pain and trauma. Additionally, many stated that there 
is nothing else for them to do, citing local areas that are so economically and 
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socially depressed.161 There is a great need for larger scale, systemic changes 
which must address the underlying determinants of health: the economy, poverty, 
childhood experiences, and social and environmental injustice, all of which 
foment and feed into causes of the epidemic.200-202 
In the meantime, public health systems are actively working to do what 
they can to mitigate symptoms of the drug use epidemic while simultaneously 
attempting the daunting task of tackling larger solutions to underlying causes. 
While it is good and necessary that funding is being allocated towards the deadly 
and costly consequences of existing addiction, a major shift in national policy and 
perspective is needed to prevent addiction altogether. Actions required include 
legislation strengthening social safety net systems, early childhood education, 
youth programing, and criminal justice reform, as well as deep-rooted and far-
reaching interventions to address growing wealth inequality.201,203-206 Until this 
radical shift happens, harm reduction is saving lives and giving people the 
possibility of a future.  
The KIRP Harm Reduction Initiative was conceived out of a need for 
Kentucky to address the crises of drug use and infectious disease, and it was 
necessary to evaluate this program in order to ascertain whether the resources 
are being used appropriately and most effectively. The purpose of this study was 
to conduct qualitative formative evaluation research on the Harm Reduction 
Initiative with the aim to identify the need for the program, clarify the program, 
inform implementation, and improve the program where necessary. The success 
or failure of the program has serious implications for the future health and 
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economic status of Kentucky. Therefore, we must assess whether this program 
operates at the highest standards, quality, and relevancy. 
As discussed, the Harm Reduction Initiative identified actual, pressing 
needs within the state, and importantly, within local jurisdictions and created an 
adequate framework to carry out appropriate local-level activities to address 
those needs. Additionally, this evaluation has presented recommendations that 
are opportunities to further improve a well-structured program. In program 
management, flexibility, adaptation, and growth are important. In order to remain 
effective and relevant, services must be restructured when necessary to address 
real and current issues affecting individuals at any given time. In this regard, the 
Harm Reduction Initiative is as prepared as can be, as it has shown itself capable 
of the flexibility and adaptation necessary to continue vital services for 
communities in Kentucky. 
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APPENDIX B: Ryan White Allowable Services 
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APPENDIX C: HRI Informational Handout 
 
 
147 
 
 
 
 
 
 
148 
 
APPENDIX D: HRI Position Posting Example
 
149 
 
 
 
150 
 
 
 
  
151 
APPENDIX E: 
 
 
152 
 
 
 
 
 
153 
APPENDIX F: HRI Quarterly Report 
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APPENDIX G: NASTAD Program Evaluation Tool 
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